<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlm.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Immunogenetics</journal-id><journal-title>Immunogenetics</journal-title><issn pub-type="ppub">0093-7711</issn><issn pub-type="epub">1432-1211</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19705113</article-id><article-id pub-id-type="publisher-id">392</article-id><article-id pub-id-type="doi">10.1007/s00251-009-0392-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Distinct genetic control of parasite elimination, dissemination, and disease after <italic>Leishmania major</italic> infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kurey</surname><given-names>Iryna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kobets</surname><given-names>Tetyana</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Havelkov&#x000e1;</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Slapni&#x0010d;kov&#x000e1;</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Quan</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Trtkov&#x000e1;</surname><given-names>Kate&#x00159;ina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grekov</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Svobodov&#x000e1;</surname><given-names>Milena</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stassen</surname><given-names>Alphons P.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hutson</surname><given-names>Alan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Demant</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Lipoldov&#x000e1;</surname><given-names>Marie</given-names></name><address><phone>+420-241-063243</phone><fax>+420-224-310955</fax><email>lipoldova@img.cas.cz</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, V&#x000ed;de&#x00148;sk&#x000e1; 1083, 142 20 Prague 4, Czech Republic </aff><aff id="Aff2"><label>2</label>Roswell Park Cancer Institute, Buffalo, NY 14263 USA </aff><aff id="Aff3"><label>3</label>Faculty of Science, Charles University, 128 44 Prague, Czech Republic </aff><aff id="Aff4"><label>4</label>Department of Clinical Genomics, University of Maastricht, Maastricht, The Netherlands </aff><aff id="Aff5"><label>5</label>Laboratory of Molecular Pathology and Institute of Pathology, Faculty of Medicine, Palack&#x000fd; University, Hn&#x0011b;vot&#x000ed;nsk&#x000e1; 3, Olomouc, Czech Republic </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>8</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2009</year></pub-date><volume>61</volume><issue>9</issue><fpage>619</fpage><lpage>633</lpage><history><date date-type="received"><day>24</day><month>7</month><year>2009</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="EN"><p>Elimination of pathogens is the basis of host resistance to infections; however, relationship between persisting pathogens and disease has not been clarified. <italic>Leishmania major</italic> infection in mice is an important model of host&#x02013;pathogen relationship. Infected BALB/c mice exhibit high parasite numbers in lymph nodes and spleens, and a chronic disease with skin lesions, splenomegaly, and hepatomegaly, increased serum IgE levels and cytokine imbalance. Although numerous gene loci affecting these disease symptoms have been reported, genes controlling parasites&#x02019; elimination or dissemination have never been mapped. We therefore compared genetics of the clinical and immunologic symptomatology with parasite load in (BALB/c&#x02009;&#x000d7;&#x02009;CcS-11) F<sub>2</sub> hybrids and mapped five loci, two of which control parasite elimination or dissemination. <italic>Lmr5</italic> influences parasite loads in spleens (and skin lesions, splenomegaly, and serum IgE, IL-4, and IFN&#x003b3; levels), and <italic>Lmr20</italic> determines parasite numbers in draining lymph nodes (and serum levels of IgE and IFN&#x003b3;), but no skin or visceral pathology. Three additional loci do not affect parasite numbers but influence significantly the disease phenotype&#x02014;<italic>Lmr21</italic>: skin lesions and IFN&#x003b3; levels, <italic>Lmr22</italic>: IL-4 levels, <italic>Lmr23:</italic> IFN&#x003b3; levels, indicating that development of <italic>L. major</italic>-caused disease includes critical regulations additional to control of parasite spread.</p></abstract><kwd-group><title>Keywords</title><kwd><italic>Leishmania major</italic></kwd><kwd>Mouse</kwd><kwd>Genetics of parasite elimination</kwd><kwd>Susceptibility to leishmaniasis</kwd><kwd>Functional heterogeneity</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><p>Parasite infection induces in the host both the responses that limit parasite growth and multiplication and responses that are either neutral or can lead to damage of host&#x02019;s tissues. Interaction between the infecting parasite and the host&#x02019;s immune system is especially important for understanding of pathogenesis of diseases caused by chronic infections.</p><p>One of the important unresolved questions in pathogenesis of chronic infections is the relationship between the pathogen load and clinical symptoms. Whereas early elimination of infectious agents generally precludes development of chronic disease, the relationship between load and spread of persisting pathogens and manifestations and course of ensuing disease has not been clarified. Although the number of studies addressing this problem is limited, they provided examples of unexpected genetic and functional complexity in infections with various pathogens such as <italic>Borrelia burgdorferi</italic> (Ma et al. <xref ref-type="bibr" rid="CR29">1998</xref>), <italic>Toxoplasma gondii</italic> (Johnson et al. <xref ref-type="bibr" rid="CR20">2002</xref>), and <italic>Trypanosoma cruzi</italic> (Marinho et al. <xref ref-type="bibr" rid="CR30">2004</xref>). This involved strain differences in both the relationship between pathogen load and intensity of symptoms of disease and in dissemination to different organs. However, the relationship between genetic control of parasite load and parasite-induced pathology has never been analyzed simultaneously in segregating populations (R&#x000e5;berg et al. <xref ref-type="bibr" rid="CR38">2007</xref>).</p><p><italic>Leishmania</italic> infection in mice has served as a paradigm of interaction of pathogen and host. <italic>Leishmania</italic> parasites are transmitted to vertebrate hosts by infected phlebotomine sandflies and infect professional phagocytes (macrophages, monocytes, and neutrophils) as well as dendritic cells and fibroblasts. The major host cell is macrophage, in which parasites multiply, eventually rupturing the cell and spreading to uninfected cells. They affect skin, mucous membranes, lymph nodes, spleen, bone marrow, liver, lungs, and, in rare cases, even the brain. The expansion of the parasites is determined by multiple factors, including both parasite characteristics (reviewed in McMahon-Pratt and Alexander <xref ref-type="bibr" rid="CR32">2004</xref>) and host genetics (reviewed in Lipoldov&#x000e1; and Demant <xref ref-type="bibr" rid="CR25">2006</xref>). <italic>Leishmania</italic> parasites can evade the first-line defense systems, inhibit several functions of host&#x02019;s immune cells (Olivier et al. <xref ref-type="bibr" rid="CR36">2005</xref>), and prime the development of an immune state favorable for the parasite. In the mouse model, distinct clinical manifestation of cutaneous and visceral leishmaniasis observed in humans can be reproduced in some mouse strains. Mice from several strains (BALB/c, SWR/J, P/J) develop severe systemic disease affecting skin and visceral organs (Sacks and Noben-Trauth <xref ref-type="bibr" rid="CR43">2002</xref>), whereas mice of the majority of inbred strains (e.g., C3H, CBA, C57BL/6, B10.D2, 129/Sv, and STS/A) after infection with <italic>L. major</italic> develop no pathological changes or only small spontaneously healing cutaneous lesions restricted to the infection site. The wide spectrum of clinical symptoms and immunological reactions in susceptible strains provides an opportunity to define control of individual components of disease phenotype. However, there are no data about the relationship of parasite load to manifestations of disease.</p><p>As the non-healer phenotype of BALB/c mice is controlled by multiple genes, we used a special tool for genetic analysis of multigenic traits, the recombinant congenic (RC) strains. Each of the 20 CcS/Dem RC mouse strains carries a different random subset of 12.5% genes of the resistant donor strain STS/A (STS) on the background of the susceptible strain BALB/cHeA (BALB/c). As a consequence, the individual STS genes contributing to the resistance to infection <italic>L. major</italic> were distributed among different RC strains. Previously, we studied three CcS/Dem strains: the most resistant strain CcS-5, the strain CcS-20 that exhibits intermediate susceptibility, and the susceptible strain CcS-16. This resulted in mapping of 17 loci, <italic>Lmr3</italic>&#x02013;<italic>Lmr19</italic> (<italic>Leishmania major</italic> response 3&#x02013;19), which are associated with 13 different combinations of pathological symptoms and immunological reactions (Lipoldov&#x000e1; et al. <xref ref-type="bibr" rid="CR26">2000</xref>; Badalov&#x000e1; et al. <xref ref-type="bibr" rid="CR1">2002</xref>; Vladimirov et al. <xref ref-type="bibr" rid="CR49">2003</xref>; Havelkov&#x000e1; et al. <xref ref-type="bibr" rid="CR16">2006</xref>).</p><p>In the present study, in addition to the disease symptoms and immunological parameters, we also measured load of parasites in draining lymph nodes and spleen. This allowed us to analyze for the first time the genetic relationship between the presence of parasites and manifestations of disease. We mapped genes controlling these parameters in the strain CcS-11, which after infection presents smaller skin lesions, lower splenomegaly and hepatomegaly, fewer parasites in spleen, and lower concentrations of IgE and IL-4 in serum than the susceptible strain BALB/c (Lipoldov&#x000e1; et al. <xref ref-type="bibr" rid="CR27">2002</xref> and this paper). We show here that the degree of elimination of parasites is genetically controlled and that this control is organ specific. Different genes control parasite load predominantly in lymph nodes or in spleen. Moreover, we show that additional genes that do not affect parasites&#x02019; presence in these two organs also significantly affect the course of disease.</p><sec id="Sec1" sec-type="materials|methods"><title>Materials and methods</title><p><bold>Mice</bold> Males and females of strains BALB/c and CcS-11 were 8 to 24 weeks old at the time of infection. When used for these experiments, strain CcS-11 was in more than 38 generations of inbreeding. The parts of its genome inherited from the BALB/c or STS parents were defined (Stassen et al. <xref ref-type="bibr" rid="CR45">1996</xref>). Two hundred and ninety-nine F<sub>2</sub> hybrids between CcS-11 and BALB/c (age 9 to 13 weeks at the time of infection, mean age 11 weeks, median 12 weeks) were produced at the Institute of Molecular Genetics. They comprised 155 females and 144 males. During the experiment, male and female mice were placed into separate rooms and males were caged individually. They were tested in three successive experimental groups. The research had complied with all relevant European Union guidelines for work with animals.</p><p><bold>Parasites</bold><italic>Leishmania major</italic> LV 561 (MHOM/IL/67/LRC-L137 JERICHO II) was maintained in rump lesions of BALB/c females. Amastigotes were transformed to promastigotes using SNB-9 (Diamond and Herman <xref ref-type="bibr" rid="CR12">1954</xref>). Promastigotes (10<sup>7</sup>) from 6-day-old subculture 2 were inoculated in 50 &#x003bc;l sterile saline s.c. into mouse rump.</p><p><bold>Disease phenotype</bold> The size of the primary skin lesions was measured weekly using a Vernier caliper gauge. The mice were killed 8 weeks after infection. Blood, spleen, liver, and inguinal lymph nodes were collected for further analysis.</p><p><bold>Quantification of parasite load in spleens and inguinal lymph nodes by PCR&#x02013;ELISA</bold> Total DNA from spleens and inguinal lymph nodes was prepared using a standard proteinase procedure. To detect <italic>Leishmania</italic> DNA by PCR, two primers (digoxigenin-labeled F 5&#x02032;-ATT TTA CAC CAA CCC CCA GTT-3&#x02032; and biotin-labeled R 5&#x02032;-GTG GGG AGG GGG CGT TCT-3&#x02032;; Rodgers et al. <xref ref-type="bibr" rid="CR41">1990</xref>; VBC-GENOMICS Biosciences Research, Vienna, Austria) were used for amplification of the 120-bp conservative region of the minicircle kinetoplast of <italic>Leishmania</italic> parasites. Briefly, 50 ng of extracted DNA with 5 pmol of each kinetoplast primer, 0.5 mM concentration of each dNTP, 2 mM MgCl<sub>2</sub>, 50 mM KCl, 10 mM Tris&#x02013;HCl (pH 8.3), and 2 U of Taq polymerase (Invitrogen Brazil Ltda., S&#x000e3;o Paulo, Brazil) was amplified in a total volume of PCR reaction of 20 &#x003bc;l. As a positive control, we used 20 ng of <italic>L. major</italic> DNA per reaction (0.3 fg of <italic>L. major</italic> DNA approximately corresponds to one parasite). After an initial hot start at 94&#x000b0;C for 90 s, the conditions used for amplification were: 94&#x000b0;C for 30 s, 53&#x000b0;C for 45 s, 72&#x000b0;C for 60 s (26 cycles for DNA from lymph nodes and 33 cycles for DNA from spleens), followed by the final extension 72&#x000b0;C for 10 min, using the I-Cycler (Bio-Rad Laboratories, Hercules, CA, USA). Concentration of the amplified 120-bp region of <italic>Leishmania</italic> DNA in PCR product was determined using the modified ELISA protocol (Pharmingen, San Diego, CA, USA). Plates were coated with 100 &#x003bc;l per well streptavidin solution (0.5 &#x003bc;g/ml in 0.1 M NaHCO<sub>3</sub> pH 7.0) at 4&#x000b0;C overnight. PCR samples were diluted to 2% concentration in 2% FCS/PBS. The positive PCR control was used as a standard for ELISA. Plates were incubated at room temperature for 2 h and then incubated at room temperature for 45 min with the anti-digoxigenin detecting antibody, Fab fragments (Roche Diagnostic GmbH, Mannheim, Germany) 0.15 U/ml, diluted in 2% FCS/PBS. As a substrate for color reaction development, we used 2,2&#x02032;-azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid) (ABTS) solution (150 mg ABTS in 500 ml 0.1 M citric acid, pH 4.35) (Sigma-Aldrich Co., St. Louis, MO, USA) with 0.03% H<sub>2</sub>O<sub>2</sub>. The color reaction was stopped after 10 min by adding 50 &#x003bc;l 0.5 M oxalic acid per well. The <italic>Leishmania</italic> loads were determined using the ELISA Reader Tecan and the curve fitter program KIM-E (Schoeller Pharma, Prague, Czech Republic) using least squares-based linear regression analysis.</p><p><bold>Cytokine and IgE levels</bold> IFN&#x003b3;, IL-4, IL-12, and IgE levels in serum were determined using the primary and secondary monoclonal antibodies (IFN&#x003b3;&#x02009;=&#x02009;R4-6A2, XMG1.2; IL-4&#x02009;=&#x02009;BVD4-1D11, BVD6-24G2; IL-12&#x02009;=&#x02009;Red-T and G297-298; IgE&#x02009;=&#x02009;R35-72, R3592) and standards from Pharmingen, San Diego, CA (recombinant mIFN&#x003b3;, mIL-4, mIL-12 p70 heterodimer, and purified mIgE&#x02009;=&#x02009;C38-2). The ELISA measurements of IFN&#x003b3;, IL-4, IL-12, and IgE levels were performed as described in the previous section.</p><p><bold>Genotyping of F<sub>2</sub> mice</bold> DNA was isolated from tails using a standard proteinase procedure. The strain CcS-11 differs from BALB/c at STS-derived segments on eight chromosomes, respectively (Stassen et al. <xref ref-type="bibr" rid="CR45">1996</xref>). These differential segments were typed in the F<sub>2</sub> hybrid mice between CcS-11 and BALB/c using 16 microsatellite markers (Research Genetics, Huntsville, FL, USA): D1Mit403, D3Mit45, D7Mit54, D7Mit18, D7Nds1, D7Mit282, D7Mit67, D7Mit259, D8Mit85, D10Mit12, D10Mit46, D12Mit37, D16Mit73, D19Mit51, D19Mit60, and D19Mit46. The maximal distance between any two markers in the chromosomal segments derived from the strain STS or from the nearest BALB/c derived markers was 19 cM.The PCR genotyping of polymorphic simple sequence length markers with fragment length difference of more than 10 bp was performed using unlabeled primers (D1Mit403, D7Mit18, D7Nds1, D7Mit282, D7Mit67, D7Mit259, D10Mit12, D10Mit46, D12Mit37, D16Mit73, D19Mit51, D19Mit60, and D19Mit46). DNA was amplified in a 20-&#x000b5;l PCR reaction with 0.11 &#x003bc;M of forward and reverse primer, 0.2 mM concentration of each dNTP, 1.0&#x02013;3.0 mM MgCl<sub>2</sub> (the optimal concentration for the most primers was 1.5 mM), 50 mM KCl, 10 mM Tris&#x02013;HCl (pH&#x02009;8.3), 0.5 U of Taq polymerase (GIBCO, Grand Island, NY, USA), and approximately 40 ng of tail DNA. PCR reaction was performed using the I-Cycler (Bio-Rad Laboratories), according to the following scheme: an initial hot start 3 min at 94&#x000b0;C, followed by 40 cycles of 94&#x000b0;C for 30 s for denaturing, 55&#x000b0; for 60 s for annealing (except markers D7Mit18 and D7Mit259, for which optimal <italic>T</italic><sub>a</sub>&#x02009;=&#x02009;57&#x000b0;), 72&#x000b0; for 60 s for elongation, and finally 3 min at 72&#x000b0; for final extension. Each PCR product was mixed with 5 &#x003bc;l of loading buffer and electrophoresed in 2<bold>&#x02013;</bold>3% agarose gel for 20 min to 1.5 h at 150 V. The PCR genotyping for simple sequence length polymorphic markers with fragment length difference of less than 10 bp (D3Mit45, D7Mit54, and D8Mit85) was performed using [&#x003b3;-<sup>32</sup>P]ATP end-labeled primers as described elsewhere (Krulov&#x000e1; et al. <xref ref-type="bibr" rid="CR21">1997</xref>).</p><p><bold>Statistical analysis</bold> The linkage of genes that control parasite spread, organ pathology, and immune parameters with microsatellite markers was examined with analysis of variance (NCSS, Kaysville, UT, USA) and PROC GLM statement of SAS 8.2 for Windows (SAS Institute, Gary, NC, USA). Genotype, sex, and age were fixed factors and the experiment was random factor. In order to obtain normal distribution, the obtained values of dependent variables were transformed as shown in the legends of the tables. We tested individual effects of all markers as well as of all their pairwise combinations using the backward elimination procedure (Tripodis et al. <xref ref-type="bibr" rid="CR48">2001</xref>). The phenotypes of compound genotypes that significantly deviated from simple additive effects of the alleles indicated interactions. Markers and interactions with <italic>P</italic> &#x0003c;0.05 were combined in a single comparison.The time course of skin lesion development was evaluated on the basis of weekly measurements of lesion size in each mouse in weeks 4 to 8 after infection. Mixed model of analysis of variance (Proc Mixed, SAS) with marker as the fixed variable, the week of observation as the covariate, and mouse as random variable have been used to evaluate the linkage.The percentage of variance explained by an independent variable, the partial <italic>R</italic><sup>2</sup>, was computed in the standard way by subtracting the regression sums of squares of the model without the variable of interest (SS(<italic>&#x003b2;</italic><sub>1</sub>, <italic>&#x003b2;</italic><sub>2</sub>, <italic>&#x003b2;</italic><sub>3</sub>, <italic>&#x003b2;</italic><sub><italic>4</italic></sub>/<italic>&#x003b2;</italic><sub><italic>0</italic></sub>)) from the regression sums of squares of the full model (SS(<italic>&#x003b2;</italic><sub>1</sub>, <italic>&#x003b2;</italic><sub>2</sub>, <italic>&#x003b2;</italic><sub><italic>3</italic></sub>, <italic>&#x003b2;</italic><sub><italic>4</italic></sub>, <italic>&#x003b2;</italic><sub>5</sub>/<italic>&#x003b2;</italic><sub>0</sub>)); this difference divided by the residual sums of squares (RSS(<italic>&#x003b2;</italic><sub>1</sub>, <italic>&#x003b2;</italic><sub>2</sub>, <italic>&#x003b2;</italic><sub>3</sub>, <italic>&#x003b2;</italic><sub><italic>4</italic></sub>, <italic>&#x003b2;</italic><sub>5</sub>/<italic>&#x003b2;</italic><sub>0</sub>)) algebraically expressed as <disp-formula id="Equa"><tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \frac{{\left( {{\text{SS}}\left( {\beta_1, \beta_2, \beta_3, \beta_4 /\beta_0 } \right)} \right) - \left( {{\text{SS}}\left( {\beta_1, \beta_2, \beta_3, \beta_4, \beta_5 /\beta_0 } \right)} \right)}}{{{\text{RSS}}\left( {\beta_1, \beta_2, \beta_3, \beta_4, \beta_5 /\beta_0 } \right)}} $$\end{document}</tex-math></disp-formula>indicated the contribution of the independent variable.To obtain genome-wide significance values (corrected <italic>P</italic>), the observed <italic>P</italic> values (<italic>&#x003b1;</italic><sub>T</sub>) were adjusted according to Lander and Schork (<xref ref-type="bibr" rid="CR23">1994</xref>) using the formula: <disp-formula id="Equb"><tex-math id="M2">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \alpha_T * \approx \left[ {C + 2\rho Gh(T)} \right]\alpha_T $$\end{document}</tex-math></disp-formula>where <italic>G</italic>&#x02009;=&#x02009;1.75 M (the length of the segregating part of the genome&#x02009;=&#x02009;12.5% of 14 M), <italic>C</italic>&#x02009;=&#x02009;8 (number of chromosomes segregating in cross between CcS-11 and BALB/c, respectively); <italic>&#x003c1;</italic>&#x02009;=&#x02009;1.5 for F<sub>2</sub> hybrids; <italic>h</italic>(<italic>T</italic>)&#x02009;=&#x02009;the observed statistic (<italic>F</italic> ratio). Direct comparisons of this method with permutation analyses in establishing genome-wide significance thresholds found them comparable (Singer et al. <xref ref-type="bibr" rid="CR44">2005</xref>).Power computation for detection of sex difference in marker effects on parasite load were carried forth. Across genotypes (D1Mit403, D10Mit12), the sample size was balanced between males (<italic>n</italic>&#x02009;=&#x02009;144) and females (<italic>n</italic>&#x02009;=&#x02009;144) for D1Mit403 and males (<italic>n</italic>&#x02009;=&#x02009;143) and females (<italic>n</italic>&#x02009;=&#x02009;146) for D10Mit12. The marker frequencies for each genotype ranged for CC from 59 to 65, for CS from 149 to 157, and for SS from 66 to 79. Under these sample sizes, we were able to detect on the log scale at 0.80 power and <italic>&#x003b1;</italic>&#x02009;=&#x02009;0.05 (two-sided) effect sizes for sex by marker interaction in ranges from 0.75 to 0.86 standard deviation units or larger, depending upon the specific differential effect.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><p><bold>Differences in organ pathology and immune response between strains CcS-11 and BALB/c</bold> The parasite load, disease symptoms, and immunological parameters in BALB/c and CcS-11 mice are given in Table <xref rid="Tab1" ref-type="table">1</xref>. BALB/c mice develop larger skin lesions during the course of infection (weeks&#x02009;5, 6, 7, and 8) and larger splenomegaly and hepatomegaly compared to the strain CcS-11, with no significant sex difference in size of skin lesions, splenomegaly, and hepatomegaly (data not shown). Larger numbers of parasites in spleen were also observed in strain BALB/c, but there were no significant differences in parasite load in draining lymph nodes. Parasite numbers in spleens of strain CcS-11 and in draining lymph nodes of both BALB/c and CcS-11 were significantly higher in males (Table <xref rid="Tab1" ref-type="table">1</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Serum IgE and IL-4 levels were higher in strain BALB/c than in strain CcS-11, but there were no strain differences in serum concentrations of IFN&#x003b3; and IL-12. Serum IgE and cytokine levels were not influenced by sex (Table <xref rid="Tab1" ref-type="table">1</xref>). <table-wrap id="Tab1"><label>Table 1</label><caption><p>Comparison of immunopathological parameters in <italic>L. major</italic> infected mice of the strains BALB/c and CcS-11</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Phenotype</th><th colspan="4">Strain</th><th><italic>P</italic> value</th></tr><tr><th/><th>BALB/c</th><th/><th>CcS-11</th><th>Strain difference</th></tr></thead><tbody><tr><td>Lesion size 5 weeks (mm<sup>2</sup>)</td><td/><td><bold>60.79&#x02009;&#x000b1;&#x02009;6.33</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td/><td><bold>29.55&#x02009;&#x000b1;&#x02009;6.33</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>1.34&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td></tr><tr><td>Lesion size 6 weeks (mm<sup>2</sup>)</td><td/><td><bold>91.67&#x02009;&#x000b1;&#x02009;7.78</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td/><td><bold>41.33&#x02009;&#x000b1;&#x02009;7.78</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>5.88&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td>Lesion size 7 weeks (mm<sup>2</sup>)</td><td/><td><bold>107.42&#x02009;&#x000b1;&#x02009;9.52</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td/><td><bold>46.54&#x02009;&#x000b1;&#x02009;9.52</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>6.91&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td>Lesion size 8 weeks (mm<sup>2</sup>)</td><td/><td><bold>129.31&#x02009;&#x000b1;&#x02009;11.73</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td/><td><bold>55.05&#x02009;&#x000b1;&#x02009;11.73</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>7.86&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td>Splenomegaly (spleen-to-body weight ratio&#x02009;&#x000d7;&#x02009;1,000)</td><td/><td><bold>17.84&#x02009;&#x000b1;&#x02009;1.13</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td/><td><bold>12.26&#x02009;&#x000b1;&#x02009;1.13</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>1.51&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td></tr><tr><td>Hepatomegaly (liver-to-body weight ratio&#x02009;&#x000d7;&#x02009;1,000)</td><td/><td><bold>68.06&#x02009;&#x000b1;&#x02009;1.55</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td/><td><bold>60.32&#x02009;&#x000b1;&#x02009;1.55</bold> (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>2.75&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td></tr><tr><td>IgE in serum (&#x003bc;g/ml)</td><td><bold>10.22</bold></td><td>3.54&#x02009;&#x000b1;&#x02009;0.29 (<italic>n</italic>&#x02009;=&#x02009;16)</td><td><bold>3.97</bold></td><td>1.62&#x02009;&#x000b1;&#x02009;0.28 (<italic>n</italic>&#x02009;=&#x02009;18)</td><td>6.79&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td>IFN&#x003b3; in serum (ng/ml)</td><td><bold>5.57</bold></td><td>1.31&#x02009;&#x000b1;&#x02009;0.05 (<italic>n</italic>&#x02009;=&#x02009;18)</td><td><bold>4.45</bold></td><td>1.22&#x02009;&#x000b1;&#x02009;0.06 (<italic>n</italic>&#x02009;=&#x02009;14)</td><td>0.257</td></tr><tr><td>IL-12 in serum (ng/ml)</td><td><bold>2.83</bold></td><td>1.04&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;16)</td><td><bold>1.74</bold></td><td>0.55&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;15)</td><td>0.119</td></tr><tr><td>IL-4 in serum (ng/ml)</td><td><bold>4.65</bold></td><td>1.61&#x02009;&#x000b1;&#x02009;0.23 (<italic>n</italic>&#x02009;=&#x02009;12)</td><td><bold>2.33</bold></td><td>0.83&#x02009;&#x000b1;&#x02009;0.26 (<italic>n</italic>&#x02009;=&#x02009;9)</td><td>3.75&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></td></tr><tr><td>Parasites in draining lymph nodes, total group (arbitrary units)</td><td><bold>1.61</bold></td><td>5.08&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;17)</td><td><bold>2.30</bold></td><td>5.44&#x02009;&#x000b1;&#x02009;0.19 (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>0.211</td></tr><tr><td>Parasites in draining lymph nodes, females</td><td><bold>0.57</bold></td><td>4.04&#x02009;&#x000b1;&#x02009;0.23<sup>a</sup> (<italic>n</italic>&#x02009;=&#x02009;9)</td><td><bold>0.46</bold></td><td>3.83&#x02009;&#x000b1;&#x02009;0.22<sup>b</sup> (<italic>n</italic>&#x02009;=&#x02009;10)</td><td>0.643</td></tr><tr><td>Parasites in draining lymph nodes, males</td><td><bold>9.28</bold></td><td>6.83&#x02009;&#x000b1;&#x02009;0.37<sup>a</sup> (<italic>n</italic>&#x02009;=&#x02009;8)</td><td><bold>8.54</bold></td><td>6.75&#x02009;&#x000b1;&#x02009;0.35<sup>b</sup> (<italic>n</italic>&#x02009;=&#x02009;9)</td><td>0.931</td></tr><tr><td>Parasites in spleen, total group (arbitrary units)</td><td><bold>1.58</bold></td><td>5.06&#x02009;&#x000b1;&#x02009;0.29 (<italic>n</italic>&#x02009;=&#x02009;18)</td><td><bold>0.31</bold></td><td>3.43&#x02009;&#x000b1;&#x02009;0.28 (<italic>n</italic>&#x02009;=&#x02009;19)</td><td>4.02&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td></tr><tr><td>Parasites in spleen, females</td><td><bold>1.10</bold></td><td>4.70&#x02009;&#x000b1;&#x02009;0.45<sup>c</sup> (<italic>n</italic>&#x02009;=&#x02009;8)</td><td><bold>0.18</bold></td><td>2.89&#x02009;&#x000b1;&#x02009;0.40<sup>d</sup> (<italic>n</italic>&#x02009;=&#x02009;10)</td><td>8.36&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td></tr><tr><td>Parasites in spleen, males</td><td><bold>3.08</bold></td><td>5.73&#x02009;&#x000b1;&#x02009;0.34<sup>c</sup> (<italic>n</italic>&#x02009;=&#x02009;10)</td><td><bold>0.58</bold></td><td>4.06&#x02009;&#x000b1;&#x02009;0.36<sup>d</sup> (<italic>n</italic>&#x02009;=&#x02009;9)</td><td>6.01&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td></tr></tbody></table><table-wrap-foot><p>Means and standard errors of means and <italic>P</italic> values were computed by analysis of variance. Lesion size (mm<sup>2</sup>), splenomegaly and hepatomegaly (spleen and liver-to-body weight ratio&#x02009;&#x000d7;&#x02009;1,000, respectively) exhibited normal distribution without transformation. The following transformations were used to obtain normal distribution: IgE levels in serum: IgE (&#x003bc;g/ml)&#x02014;natural logarithm of value to the power of 1.5; IFN&#x003b3; (ng/ml)&#x02014;natural logarithm of the value to the power of 0.5; IL-4 (ng/ml)&#x02014;natural logarithm to the power of 1.1; IL-12 (ng/ml)&#x02014;natural logarithm; parasite load detected as parasite DNA content (arbitrary units) in spleen and in lymph nodes&#x02014;natural logarithm of (value&#x02009;&#x000d7;&#x02009;100). Number of tested mice is shown in brackets. The numbers in bold give the average non-transformed values.</p><p><sup>a</sup>Sex difference in BALB/c, <italic>P</italic>&#x02009;=&#x02009;9.26&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></p><p><sup>b</sup>Sex difference in CcS-11, <italic>P</italic>&#x02009;=&#x02009;1.14&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></p><p><sup>c</sup>Sex difference in BALB/c, <italic>P</italic>&#x02009;=&#x02009;0.133</p><p><sup>d</sup>Sex difference in CcS-11, <italic>P</italic>&#x02009;=&#x02009;8.93&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Parasites in hematoxylin&#x02013;eosin-stained inguinal lymph node sections of female and male mice. <bold>a</bold> Uninfected BALB/c male, <bold>b</bold><italic>L. major</italic> infected BALB/c male, <bold>c</bold> uninfected BALB/c female, <bold>d</bold><italic>L. major</italic> infected BALB/c female, <bold>e</bold> uninfected CcS-11 male, <bold>f</bold><italic>L. major</italic> infected CcS-11 male, <bold>g</bold> uninfected CcS-11 female, <bold>h</bold><italic>L. major</italic> infected CcS-11 female. <italic>Arrows</italic> show groups of <italic>Leishmania</italic> parasites (with a dark nucleus, smaller kinetoplast, and light cytoplasm) among normal lymph node cells (<bold>b</bold>, <bold>d</bold>, <bold>f</bold>) and parasites inside a macrophage (<bold>h</bold>)</p></caption><graphic position="anchor" xlink:href="251_2009_392_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of <italic>Lmr</italic> loci that control response to <italic>L. major</italic> in the strain CcS-11</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Locus</th><th>Chr.</th><th>Marker (position in cM)</th><th>Trait controlled</th></tr></thead><tbody><tr><td><italic>Lmr20</italic></td><td>1</td><td>D1Mit403 (100)</td><td>Parasite load in draining LNs, serum IgE, serum IFN&#x003b3; (in interaction with <italic>Lmr23</italic>)</td></tr><tr><td><italic>Lmr21</italic></td><td>7</td><td>D7Mit67 (63.5)</td><td>Lesion development, serum IFN&#x003b3; (in interaction with <italic>Lmr5</italic>)</td></tr><tr><td><italic>Lmr5</italic></td><td>10</td><td>D10Mit12 (56); D10Mit46 (63)</td><td>Lesion size, parasite load in spleen, splenomegaly, serum IgE, serum IFN&#x003b3; (in interaction with <italic>Lmr21</italic>), serum IL-4 (in interaction with <italic>Lmr22</italic>)</td></tr><tr><td><italic>Lmr22</italic></td><td>12</td><td>D12Mit37 (1)</td><td>Serum IL-4 (in interaction with <italic>Lmr5</italic>)</td></tr><tr><td><italic>Lmr23</italic></td><td>16</td><td>D16Mit73 (8.6)</td><td>Serum IFN&#x003b3; (in interaction with <italic>Lmr20</italic>)</td></tr></tbody></table><table-wrap-foot><p>Only the QTLs with corrected <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 (genome-wide significance) are shown.</p></table-wrap-foot></table-wrap></p><p><bold>Loci that influence parasite burden, organ pathology, and immunological parameters in the strain CcS-11</bold> The summary of the detected loci and their phenotypic effects is given in Table <xref rid="Tab2" ref-type="table">2</xref>. Linkage analysis of F<sub>2</sub> hybrids between BALB/c and CcS-11 indicated four novel loci <italic>Lmr20</italic>, <italic>Lmr21</italic>, <italic>Lmr22</italic>, and <italic>Lmr23</italic> on chromosomes 1, 7, 12, and 16, respectively. For the previously detected locus <italic>Lmr5</italic> on chromosome 10 (Lipoldov&#x000e1; et al. <xref ref-type="bibr" rid="CR26">2000</xref>), we detected an additional effect on parasite load in spleen and on IL-4 level in serum in interaction with <italic>Lmr22</italic>. These data are given in Tables <xref rid="Tab3" ref-type="table">3</xref>, <xref rid="Tab4" ref-type="table">4</xref>, and <xref rid="Tab5" ref-type="table">5</xref> (single gene effects) and Tables <xref rid="Tab6" ref-type="table">6</xref>, <xref rid="Tab7" ref-type="table">7</xref>, and <xref rid="Tab8" ref-type="table">8</xref> (gene interactions). <table-wrap id="Tab3"><label>Table 3</label><caption><p>Loci that control parasite load in draining lymph nodes and spleens and splenomegaly in <italic>L. major</italic> infected F<sub>2</sub> hybrids between CcS-11 and BALB/c</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Phenotype</th><th rowspan="2">Locus</th><th rowspan="2">Group</th><th rowspan="2">Marker</th><th colspan="6">Genotype</th><th rowspan="2"><italic>P</italic> value</th><th rowspan="2">Corrected <italic>P</italic> value</th><th rowspan="2">Percent of explained variance</th></tr><tr><th/><th>CC</th><th/><th>CS</th><th/><th>SS</th></tr></thead><tbody><tr><td rowspan="3">Parasites in draining lymph nodes (arbitrary units)</td><td rowspan="3"><italic>Lmr20</italic></td><td>Both sexes</td><td>D1Mit403</td><td/><td><bold>7.74&#x02009;&#x000b1;&#x02009;0.51</bold> (<italic>n</italic>&#x02009;=&#x02009;66)</td><td/><td><bold>6.26&#x02009;&#x000b1;&#x02009;0.33</bold> (<italic>n</italic>&#x02009;=&#x02009;152)</td><td/><td><bold>4.35&#x02009;&#x000b1;&#x02009;0.51</bold> (<italic>n</italic>&#x02009;=&#x02009;66)</td><td>8.35&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>5.54&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>4.25</td></tr><tr><td>Females</td><td>D1Mit403</td><td/><td><bold>4.96&#x02009;&#x000b1;&#x02009;0.55</bold> (<italic>n</italic>&#x02009;=&#x02009;37)</td><td/><td><bold>3.34&#x02009;&#x000b1;&#x02009;0.40</bold> (<italic>n</italic>&#x02009;=&#x02009;70)</td><td/><td><bold>1.90&#x02009;&#x000b1;&#x02009;0.55</bold> (<italic>n</italic>&#x02009;=&#x02009;37)</td><td>1.16&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>5.89&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></td><td>8.39</td></tr><tr><td>Males</td><td>D1Mit403</td><td/><td><bold>10.87&#x02009;&#x000b1;&#x02009;0.89</bold> (<italic>n</italic>&#x02009;=&#x02009;29)</td><td/><td><bold>9.34&#x02009;&#x000b1;&#x02009;0.53</bold> (<italic>n</italic>&#x02009;=&#x02009;82)</td><td/><td><bold>7.31&#x02009;&#x000b1;&#x02009;0.89</bold> (<italic>n</italic>&#x02009;=&#x02009;29)</td><td>0.301</td><td>NS</td><td>&#x02013;</td></tr><tr><td rowspan="3">Parasites in spleen (arbitrary units)</td><td rowspan="3"><italic>Lmr5</italic></td><td>Both sexes</td><td>D10Mit12</td><td><bold>2.09</bold></td><td>5.34&#x02009;&#x000b1;&#x02009;0.14 (<italic>n</italic>&#x02009;=&#x02009;60)</td><td><bold>0.98</bold></td><td>4.58&#x02009;&#x000b1;&#x02009;0.09 (<italic>n</italic>&#x02009;=&#x02009;150)</td><td><bold>0.96</bold></td><td>4.56&#x02009;&#x000b1;&#x02009;0.12 (<italic>n</italic>&#x02009;=&#x02009;79)</td><td>8.09&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>5.39&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>4.54</td></tr><tr><td>Females</td><td>D10Mit12</td><td><bold>1.60</bold></td><td>5.07&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;31)</td><td><bold>0.60</bold></td><td>4.10&#x02009;&#x000b1;&#x02009;0.14 (<italic>n</italic>&#x02009;=&#x02009;69)</td><td><bold>0.52</bold></td><td>3.96&#x02009;&#x000b1;&#x02009;0.17 (<italic>n</italic>&#x02009;=&#x02009;46)</td><td>8.57&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>5.76&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>11.74</td></tr><tr><td>Males</td><td>D10Mit12</td><td><bold>2.57</bold></td><td>5.55&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;29)</td><td><bold>1.70</bold></td><td>5.14&#x02009;&#x000b1;&#x02009;0.12 (<italic>n</italic>&#x02009;=&#x02009;81)</td><td><bold>2.15</bold></td><td>5.37&#x02009;&#x000b1;&#x02009;0.18 (<italic>n</italic>&#x02009;=&#x02009;33)</td><td>0.173</td><td>NS</td><td>&#x02013;</td></tr><tr><td rowspan="6">Splenomegaly (spleen-to-body weight ratio&#x02009;&#x000d7;&#x02009;1,000)</td><td rowspan="6"><italic>Lmr5</italic></td><td rowspan="2">Both sexes</td><td>D10Mit12</td><td/><td><bold>21.43</bold>&#x02009;&#x000b1;&#x02009;<bold>0.61</bold> (<italic>n</italic>&#x02009;=&#x02009;62)</td><td/><td><bold>18.82</bold>&#x02009;&#x000b1;&#x02009;<bold>0.39</bold> (<italic>n</italic>&#x02009;=&#x02009;151)</td><td/><td><bold>17.49&#x02009;&#x000b1;&#x02009;0.53</bold> (<italic>n</italic>&#x02009;=&#x02009;82)</td><td>8.63&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>6.98&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>11.60</td></tr><tr><td>D10Mit46</td><td/><td><bold>20.64&#x02009;&#x000b1;&#x02009;0.63</bold> (<italic>n</italic>&#x02009;=&#x02009;61)</td><td/><td><bold>18.76&#x02009;&#x000b1;&#x02009;0.40</bold> (<italic>n</italic>&#x02009;=&#x02009;151)</td><td/><td><bold>17.52&#x02009;&#x000b1;&#x02009;0.56</bold> (<italic>n</italic>&#x02009;=&#x02009;76)</td><td>1.27&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>6.21&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></td><td>4.32</td></tr><tr><td rowspan="2">Females</td><td>D10Mit12</td><td/><td><bold>22.59&#x02009;&#x000b1;&#x02009;0.86</bold> (<italic>n</italic>&#x02009;=&#x02009;33)</td><td/><td><bold>19.06&#x02009;&#x000b1;&#x02009;0.59</bold> (<italic>n</italic>&#x02009;=&#x02009;70)</td><td/><td><bold>16.91&#x02009;&#x000b1;&#x02009;0.71</bold> (<italic>n</italic>&#x02009;=&#x02009;48)</td><td>6.48&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>5.57&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>14.47</td></tr><tr><td>D10Mit46</td><td/><td><bold>22.56&#x02009;&#x000b1;&#x02009;0.96</bold> (<italic>n</italic>&#x02009;=&#x02009;28)</td><td/><td><bold>19.42&#x02009;&#x000b1;&#x02009;0.59</bold> (<italic>n</italic>&#x02009;=&#x02009;73)</td><td/><td><bold>17.27&#x02009;&#x000b1;&#x02009;0.72</bold> (<italic>n</italic>&#x02009;=&#x02009;49)</td><td>1.06&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>7.08&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>11.50</td></tr><tr><td rowspan="2">Males</td><td>D10Mit12</td><td/><td><bold>19.42&#x02009;&#x000b1;&#x02009;0.84</bold> (<italic>n</italic>&#x02009;=&#x02009;29)</td><td/><td><bold>18.29&#x02009;&#x000b1;&#x02009;0.50</bold> (<italic>n</italic>&#x02009;=&#x02009;81)</td><td/><td><bold>17.71&#x02009;&#x000b1;&#x02009;0.77</bold> (<italic>n</italic>&#x02009;=&#x02009;34)</td><td>0.318</td><td>NS</td><td>&#x02013;</td></tr><tr><td>D10Mit46</td><td/><td><bold>18.78&#x02009;&#x000b1;&#x02009;0.78</bold> (<italic>n</italic>&#x02009;=&#x02009;33)</td><td/><td><bold>18.07&#x02009;&#x000b1;&#x02009;0.51</bold> (<italic>n</italic>&#x02009;=&#x02009;78)</td><td/><td><bold>18.34&#x02009;&#x000b1;&#x02009;0.87</bold> (<italic>n</italic>&#x02009;=&#x02009;27)</td><td>0.750</td><td>NS</td><td>&#x02013;</td></tr></tbody></table><table-wrap-foot><p>Mean and SE values were obtained by analysis of variance. Only linkages significant at whole genome level in the total group or in at least in one sex are given. The parasite loads were estimated by PCR&#x02013;ELISA (see <xref rid="Sec1" ref-type="sec">Materials and methods</xref>). In order to obtain normal distribution required for analysis of variance, value of parasites in spleens was transformed to the natural logarithm of (value&#x02009;&#x000d7;&#x02009;100). Splenomegaly (spleen-to-body weight ratio&#x02009;&#x000d7;&#x02009;1,000) and parasite load in draining lymph nodes exhibited normal distribution without transformation. The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively; <italic>n</italic> indicates number of mice.</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Loci controlling skin lesion development after infection with <italic>L. major</italic> in both sexes and separately in female and male F<sub>2</sub> hybrids between CcS-11 and BALB/c</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Locus</th><th rowspan="2">Group</th><th rowspan="2">Marker</th><th colspan="3">Genotype</th><th rowspan="2"><italic>P</italic> value</th><th rowspan="2">Corrected <italic>P</italic> value</th></tr><tr><th>CC</th><th>CS</th><th>SS</th></tr></thead><tbody><tr><td rowspan="6"><italic>Lmr5</italic></td><td rowspan="2">Both sexes</td><td>D10Mit12</td><td char="&#x000b1;" align="char"><bold>79.09&#x02009;&#x000b1;&#x02009;1.61</bold> (<italic>n</italic>&#x02009;=&#x02009;62)</td><td char="&#x000b1;" align="char"><bold>71.46&#x02009;&#x000b1;&#x02009;1.03</bold> (<italic>n</italic>&#x02009;=&#x02009;151)</td><td char="&#x000b1;" align="char"><bold>59.18&#x02009;&#x000b1;&#x02009;1.40</bold> (<italic>n</italic>&#x02009;=&#x02009;82)</td><td>1.16&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>5.27&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td>D10Mit46</td><td char="&#x000b1;" align="char"><bold>79.84&#x02009;&#x000b1;&#x02009;1.64</bold> (<italic>n</italic>&#x02009;=&#x02009;61)</td><td char="&#x000b1;" align="char"><bold>70.94&#x02009;&#x000b1;&#x02009;1.04</bold> (<italic>n</italic>&#x02009;=&#x02009;151)</td><td char="&#x000b1;" align="char"><bold>58.90&#x02009;&#x000b1;&#x02009;1.47</bold> (<italic>n</italic>&#x02009;=&#x02009;76)</td><td>1.05&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>4.83&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td rowspan="2">Females</td><td>D10Mit12</td><td char="&#x000b1;" align="char"><bold>79.06&#x02009;&#x000b1;&#x02009;2.29</bold> (<italic>n</italic>&#x02009;=&#x02009;33)</td><td char="&#x000b1;" align="char"><bold>66.16&#x02009;&#x000b1;&#x02009;1.58</bold> (<italic>n</italic>&#x02009;=&#x02009;70)</td><td char="&#x000b1;" align="char"><bold>52.01&#x02009;&#x000b1;&#x02009;1.91</bold> (<italic>n</italic>&#x02009;=&#x02009;48)</td><td>6.34&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>2.67&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td></tr><tr><td>D10Mit46</td><td char="&#x000b1;" align="char"><bold>79.19&#x02009;&#x000b1;&#x02009;2.52</bold> (<italic>n</italic>&#x02009;=&#x02009;28)</td><td char="&#x000b1;" align="char"><bold>66.60&#x02009;&#x000b1;&#x02009;1.56</bold> (<italic>n</italic>&#x02009;=&#x02009;73)</td><td char="&#x000b1;" align="char"><bold>52.26&#x02009;&#x000b1;&#x02009;1.91</bold> (<italic>n</italic>&#x02009;=&#x02009;49)</td><td>1.88&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>7.28&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td></tr><tr><td rowspan="2">Males</td><td>D10Mit12</td><td char="&#x000b1;" align="char"><bold>79.12&#x02009;&#x000b1;&#x02009;2.15</bold> (<italic>n</italic>&#x02009;=&#x02009;29)</td><td char="&#x000b1;" align="char"><bold>76.03&#x02009;&#x000b1;&#x02009;1.29</bold> (<italic>n</italic>&#x02009;=&#x02009;81)</td><td char="&#x000b1;" align="char"><bold>69.23&#x02009;&#x000b1;&#x02009;1.98</bold> (<italic>n</italic>&#x02009;=&#x02009;34)</td><td>0.147</td><td>NS</td></tr><tr><td>D10Mit46</td><td char="&#x000b1;" align="char"><bold>80.39&#x02009;&#x000b1;&#x02009;2.03</bold> (<italic>n</italic>&#x02009;=&#x02009;33)</td><td char="&#x000b1;" align="char"><bold>75.00&#x02009;&#x000b1;&#x02009;1.32</bold> (<italic>n</italic>&#x02009;=&#x02009;78)</td><td char="&#x000b1;" align="char"><bold>70.89&#x02009;&#x000b1;&#x02009;2.24</bold> (<italic>n</italic>&#x02009;=&#x02009;27)</td><td>0.207</td><td>NS</td></tr><tr><td rowspan="6"><italic>Lmr21</italic></td><td rowspan="2">Both sexes</td><td>D7Mit282</td><td char="&#x000b1;" align="char"><bold>109.53&#x02009;&#x000b1;&#x02009;3.63</bold> (<italic>n</italic>&#x02009;=&#x02009;77)</td><td char="&#x000b1;" align="char"><bold>102.90&#x02009;&#x000b1;&#x02009;2.64</bold> (<italic>n</italic>&#x02009;=&#x02009;140)</td><td char="&#x000b1;" align="char"><bold>86.35&#x02009;&#x000b1;&#x02009;3.98</bold> (<italic>n</italic>&#x02009;=&#x02009;63)</td><td>4.3&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>0.0972 (suggestive)</td></tr><tr><td>D7Mit67</td><td char="&#x000b1;" align="char"><bold>113.18&#x02009;&#x000b1;&#x02009;3.58</bold> (<italic>n</italic>&#x02009;=&#x02009;79)</td><td char="&#x000b1;" align="char"><bold>101.54&#x02009;&#x000b1;&#x02009;2.69</bold> (<italic>n</italic>&#x02009;=&#x02009;132)</td><td char="&#x000b1;" align="char"><bold>85.39&#x02009;&#x000b1;&#x02009;3.53</bold> (<italic>n</italic>&#x02009;=&#x02009;77)</td><td>4.25&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>0.0116</td></tr><tr><td rowspan="2">Females</td><td>D7Mit282</td><td char="&#x000b1;" align="char"><bold>103.20&#x02009;&#x000b1;&#x02009;4.92</bold> (<italic>n</italic>&#x02009;=&#x02009;45)</td><td char="&#x000b1;" align="char"><bold>93.89&#x02009;&#x000b1;&#x02009;3.63</bold> (<italic>n</italic>&#x02009;=&#x02009;80)</td><td char="&#x000b1;" align="char"><bold>81.06&#x02009;&#x000b1;&#x02009;6.57</bold> (<italic>n</italic>&#x02009;=&#x02009;25)</td><td>0.1012</td><td>NS</td></tr><tr><td>D7Mit67</td><td char="&#x000b1;" align="char"><bold>110.14&#x02009;&#x000b1;&#x02009;4.62</bold> (<italic>n</italic>&#x02009;=&#x02009;46)</td><td char="&#x000b1;" align="char"><bold>91.70&#x02009;&#x000b1;&#x02009;3.62</bold> (<italic>n</italic>&#x02009;=&#x02009;71)</td><td char="&#x000b1;" align="char"><bold>76.65&#x02009;&#x000b1;&#x02009;5.44</bold> (<italic>n</italic>&#x02009;=&#x02009;32)</td><td>1.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>0.0458</td></tr><tr><td rowspan="2">Males</td><td>D7Mit282</td><td char="&#x000b1;" align="char"><bold>109.67&#x02009;&#x000b1;&#x02009;5.18</bold> (<italic>n</italic>&#x02009;=&#x02009;32)</td><td char="&#x000b1;" align="char"><bold>112.75&#x02009;&#x000b1;&#x02009;3.79</bold> (<italic>n</italic>&#x02009;=&#x02009;60)</td><td char="&#x000b1;" align="char"><bold>98.87&#x02009;&#x000b1;&#x02009;4.76</bold> (<italic>n</italic>&#x02009;=&#x02009;38)</td><td>0.0895</td><td>NS</td></tr><tr><td>D7Mit67</td><td char="&#x000b1;" align="char"><bold>113.89&#x02009;&#x000b1;&#x02009;5.39</bold> (<italic>n</italic>&#x02009;=&#x02009;33)</td><td char="&#x000b1;" align="char"><bold>112.31&#x02009;&#x000b1;&#x02009;3.84</bold> (<italic>n</italic>&#x02009;=&#x02009;61)</td><td char="&#x000b1;" align="char"><bold>99.95&#x02009;&#x000b1;&#x02009;4.45</bold> (<italic>n</italic>&#x02009;=&#x02009;45)</td><td>0.172</td><td>NS</td></tr></tbody></table><table-wrap-foot><p>Mean and SE values were obtained by analysis of variance. Lesion size (mm<sup>2</sup>) exhibited normal distribution without transformation. C and S indicate the presence of BALB/c and STS allele, respectively; <italic>n</italic> indicates number of mice. The values for <italic>Lmr5</italic> were calculated by analysis of covariance from all five time points (from 4 to 8 weeks of infection) as described in <xref rid="Sec1" ref-type="sec">Materials and methods</xref>; the values for <italic>Lmr21</italic> by analysis of variance for week&#x02009;8.</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Loci controlling IgE level in <italic>L. major</italic> infected F<sub>2</sub> hybrids between CcS-11 and BALB/c</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Locus</th><th rowspan="2">Group</th><th rowspan="2">Marker</th><th colspan="6">Genotype</th><th rowspan="2"><italic>P</italic> value</th><th rowspan="2">Corrected <italic>P</italic> value</th><th rowspan="2">Percent of explained variance</th></tr><tr><th/><th>CC</th><th/><th>CS</th><th/><th>SS</th></tr></thead><tbody><tr><td rowspan="3"><italic>Lmr20</italic></td><td>Both sexes</td><td>D1Mit403</td><td><bold>21.63</bold></td><td>5.39&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;69)</td><td><bold>16.86</bold></td><td>4.75&#x02009;&#x000b1;&#x02009;0.13 (<italic>n</italic>&#x02009;=&#x02009;157)</td><td><bold>12.69</bold></td><td>4.05&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;69)</td><td>4.35&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>3.07&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>6.09</td></tr><tr><td>Females</td><td>D1Mit403</td><td><bold>19.87</bold></td><td>5.17&#x02009;&#x000b1;&#x02009;0.25 (<italic>n</italic>&#x02009;=&#x02009;39)</td><td><bold>13.25</bold></td><td>4.15&#x02009;&#x000b1;&#x02009;0.18 (<italic>n</italic>&#x02009;=&#x02009;73)</td><td><bold>10.00</bold></td><td>3.49&#x02009;&#x000b1;&#x02009;0.24 (<italic>n</italic>&#x02009;=&#x02009;41)</td><td>2.36&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>1.81&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>11.76</td></tr><tr><td>Males</td><td>D1Mit403</td><td><bold>18.54</bold></td><td>4.99&#x02009;&#x000b1;&#x02009;0.33 (<italic>n</italic>&#x02009;=&#x02009;30)</td><td><bold>17.44</bold></td><td>4.83&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;84)</td><td><bold>13.86</bold></td><td>4.26&#x02009;&#x000b1;&#x02009;0.34 (<italic>n</italic>&#x02009;=&#x02009;28)</td><td>0.235</td><td>NS</td><td>&#x02013;</td></tr><tr><td rowspan="3"><italic>Lmr5</italic></td><td>Both sexes</td><td>D10Mit12</td><td><bold>18.03</bold></td><td>4.92&#x02009;&#x000b1;&#x02009;0.22 (<italic>n</italic>&#x02009;=&#x02009;62)</td><td><bold>16.19</bold></td><td>4.65&#x02009;&#x000b1;&#x02009;0.14 (<italic>n</italic>&#x02009;=&#x02009;150)</td><td><bold>11.82</bold></td><td>3.88&#x02009;&#x000b1;&#x02009;0.19 (<italic>n</italic>&#x02009;=&#x02009;81)</td><td>5.58&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>3.02&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></td><td>4.70</td></tr><tr><td>Females</td><td>D10Mit12</td><td><bold>17.25</bold></td><td>4.81&#x02009;&#x000b1;&#x02009;0.28 (<italic>n</italic>&#x02009;=&#x02009;33)</td><td><bold>13.90</bold></td><td>4.27&#x02009;&#x000b1;&#x02009;0.19 (<italic>n</italic>&#x02009;=&#x02009;70)</td><td><bold>11.49</bold></td><td>3.81&#x02009;&#x000b1;&#x02009;0.24 (<italic>n</italic>&#x02009;=&#x02009;47)</td><td>2.98&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></td><td>NS</td><td>&#x02013;</td></tr><tr><td>Males</td><td>D10Mit12</td><td><bold>18.38</bold></td><td>4.97&#x02009;&#x000b1;&#x02009;0.33 (<italic>n</italic>&#x02009;=&#x02009;29)</td><td><bold>18.78</bold></td><td>5.02&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;80)</td><td><bold>11.92</bold></td><td>3.90&#x02009;&#x000b1;&#x02009;0.30 (<italic>n</italic>&#x02009;=&#x02009;34)</td><td>8.64&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>NS</td><td>&#x02013;</td></tr></tbody></table><table-wrap-foot><p>Mean and SE values were obtained by analysis of variance. In order to obtain normal distribution required for analysis of variance value of IgE in serum (&#x003bc;g/ml) was transformed by natural logarithm of value to the power of 1.5. The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively; <italic>n</italic> indicates number of mice.</p></table-wrap-foot></table-wrap><table-wrap id="Tab6"><label>Table 6</label><caption><p>Interactions between loci (<italic>Lmr20</italic> and <italic>Lmr23</italic>) that control level of IFN&#x003b3; in serum in <italic>L. major</italic> infected F<sub>2</sub> hybrids between CcS-11 and BALB/c</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2"/><th colspan="2">Expl. var.&#x02009;=&#x02009;6.93%</th><th colspan="2"><italic>P</italic>&#x02009;=&#x02009;5.15&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></th><th colspan="2">Corr. <italic>P&#x02009;</italic>=&#x02009;2.01&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></th></tr><tr><th colspan="6">D1Mit403 (<italic>Lmr20</italic>)</th></tr></thead><tbody><tr><td rowspan="4">D16Mit73 (<italic>Lmr23</italic>)</td><td/><td/><td>CC</td><td/><td>CS</td><td/><td>SS</td></tr><tr><td>CC</td><td><bold>14.03</bold></td><td>1.63&#x02009;&#x000b1;&#x02009;0.11 (<italic>n</italic>&#x02009;=&#x02009;11)</td><td><bold>12.05</bold></td><td>1.58&#x02009;&#x000b1;&#x02009;0.06 (<italic>n</italic>&#x02009;=&#x02009;37)</td><td><bold>7.48</bold></td><td>1.42&#x02009;&#x000b1;&#x02009;0.10 (<italic>n</italic>&#x02009;=&#x02009;16)</td></tr><tr><td>CS</td><td><bold>15.68</bold></td><td>1.66&#x02009;&#x000b1;&#x02009;0.06 (<italic>n</italic>&#x02009;=&#x02009;35)</td><td><bold>7.89</bold></td><td>1.44&#x02009;&#x000b1;&#x02009;0.05 (<italic>n</italic>&#x02009;=&#x02009;69)</td><td><bold>6.34</bold></td><td>1.36&#x02009;&#x000b1;&#x02009;0.09 (<italic>n</italic>&#x02009;=&#x02009;20)</td></tr><tr><td>SS</td><td><bold>4.36</bold></td><td>1.21&#x02009;&#x000b1;&#x02009;0.11 (<italic>n</italic>&#x02009;=&#x02009;12)</td><td><bold>6.75</bold></td><td>1.38&#x02009;&#x000b1;&#x02009;0.07 (<italic>n</italic>&#x02009;=&#x02009;33)</td><td><bold>16.95</bold></td><td>1.68&#x02009;&#x000b1;&#x02009;0.10 (<italic>n</italic>&#x02009;=&#x02009;16)</td></tr></tbody></table><table-wrap-foot><p>Mean and SE values were obtained by analysis of variance. The linkage significant at whole genome level is given. In order to obtain normal distribution, we used natural logarithm of (IFN&#x003b3; in serum [ng/ml] to the power of 0.5) and natural logarithm (IL-4 in serum [ng/ml] to the power of 1.1). The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively; <italic>n</italic> indicates number of mice.</p></table-wrap-foot></table-wrap><table-wrap id="Tab7"><label>Table 7</label><caption><p>Interactions between loci (<italic>Lmr21</italic> and <italic>Lmr5</italic>) that control level of IFN&#x003b3; in serum in <italic>L. major</italic> infected F<sub>2</sub> hybrids between CcS-11 and BALB/c</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2"/><th colspan="2">Expl. var.&#x02009;=&#x02009;7.18%</th><th colspan="2"><italic>P&#x02009;</italic>=&#x02009;4.96&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></th><th colspan="2">Corr. <italic>P&#x02009;</italic>=&#x02009;1.95&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></th></tr><tr><th colspan="6">D7Mit67 (<italic>Lmr21</italic>)</th></tr></thead><tbody><tr><td rowspan="4">D10Mit12 (<italic>Lmr5</italic>)</td><td/><td/><td>CC</td><td/><td>CS</td><td/><td>SS</td></tr><tr><td>CC</td><td><bold>4.86</bold></td><td>1.26&#x02009;&#x000b1;&#x02009;0.09 (<italic>n</italic>&#x02009;=&#x02009;18)</td><td><bold>13.66</bold></td><td>1.62&#x02009;&#x000b1;&#x02009;0.07 (<italic>n</italic>&#x02009;=&#x02009;25)</td><td><bold>21.93</bold></td><td>1.76&#x02009;&#x000b1;&#x02009;0.11 (<italic>n</italic>&#x02009;=&#x02009;11)</td></tr><tr><td>CS</td><td><bold>11.81</bold></td><td>1.57&#x02009;&#x000b1;&#x02009;0.06 (<italic>n</italic>&#x02009;=&#x02009;34)</td><td><bold>8.86</bold></td><td>1.48&#x02009;&#x000b1;&#x02009;0.05 (<italic>n</italic>&#x02009;=&#x02009;57)</td><td><bold>11.71</bold></td><td>1.57&#x02009;&#x000b1;&#x02009;0.07 (<italic>n</italic>&#x02009;=&#x02009;30)</td></tr><tr><td>SS</td><td><bold>11.59</bold></td><td>1.57&#x02009;&#x000b1;&#x02009;0.09 (<italic>n</italic>&#x02009;=&#x02009;16)</td><td><bold>6.71</bold></td><td>1.38&#x02009;&#x000b1;&#x02009;0.07 (<italic>n</italic>&#x02009;=&#x02009;30)</td><td><bold>4.91</bold></td><td>1.26&#x02009;&#x000b1;&#x02009;0.09 (<italic>n</italic>&#x02009;=&#x02009;17)</td></tr></tbody></table><table-wrap-foot><p>Mean and SE values were obtained by analysis of variance. The linkage significant at whole genome level is given. In order to obtain normal distribution, we used natural logarithm of (IFN&#x003b3; in serum [ng/ml] to the power of 0.5) and natural logarithm (IL-4 in serum [ng/ml] to the power of 1.1). The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively; <italic>n</italic> indicates number of mice.</p></table-wrap-foot></table-wrap><table-wrap id="Tab8"><label>Table 8</label><caption><p>Interactions between loci that control level of IL-4 in serum in <italic>L. major</italic> infected F<sub>2</sub> hybrids between CcS-11 and BALB/c</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2"/><th colspan="2">Expl. var.&#x02009;=&#x02009;7.71%</th><th colspan="2"><italic>P&#x02009;</italic>=&#x02009;7.04&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></th><th colspan="2">Corr. <italic>P&#x02009;</italic>=&#x02009;2.69&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup></th></tr><tr><th colspan="6">D10Mit12 (<italic>Lmr5</italic>)</th></tr></thead><tbody><tr><td rowspan="4">D12Mit37 (<italic>Lmr22</italic>)</td><td/><td/><td>CC</td><td/><td>CS</td><td/><td>SS</td></tr><tr><td>CC</td><td><bold>9.04</bold></td><td>2.38&#x02009;&#x000b1;&#x02009;0.38 (<italic>n</italic>&#x02009;=&#x02009;6)</td><td><bold>3.57</bold></td><td>1.30&#x02009;&#x000b1;&#x02009;0.19 (<italic>n</italic>&#x02009;=&#x02009;24)</td><td><bold>5.90</bold></td><td>1.88&#x02009;&#x000b1;&#x02009;0.23 (<italic>n</italic>&#x02009;=&#x02009;17)</td></tr><tr><td>CS</td><td><bold>4.57</bold></td><td>1.58&#x02009;&#x000b1;&#x02009;0.20 (<italic>n</italic>&#x02009;=&#x02009;23)</td><td><bold>7.77</bold></td><td>2.20&#x02009;&#x000b1;&#x02009;0.13 (<italic>n</italic>&#x02009;=&#x02009;55)</td><td><bold>4.15</bold></td><td>1.48&#x02009;&#x000b1;&#x02009;0.21 (<italic>n</italic>&#x02009;=&#x02009;20)</td></tr><tr><td>SS</td><td><bold>5.10</bold></td><td>1.71&#x02009;&#x000b1;&#x02009;0.23 (<italic>n</italic>&#x02009;=&#x02009;17)</td><td><bold>7.09</bold></td><td>2.09&#x02009;&#x000b1;&#x02009;0.18 (<italic>n</italic>&#x02009;=&#x02009;26)</td><td><bold>3.42</bold></td><td>1.26&#x02009;&#x000b1;&#x02009;0.24 (<italic>n</italic>&#x02009;=&#x02009;15)</td></tr></tbody></table><table-wrap-foot><p>Mean and SE values were obtained by analysis of variance. The linkage significant at whole genome level is given. In order to obtain normal distribution, we used natural logarithm of (IFN&#x003b3; in serum [ng/ml] to the power of 0.5) and natural logarithm (IL-4 in serum [ng/ml] to the power of 1.1). The numbers in bold give the average non-transformed values. C and S indicate the presence of BALB/c and STS allele, respectively; <italic>n</italic> indicates number of mice.</p></table-wrap-foot></table-wrap>These tables describing detected linkages give besides the statistical significance of linkage also two other quantitative characteristics (Lander and Botstein <xref ref-type="bibr" rid="CR22">1989</xref>) that describe the size of their effect: (a) a magnitude of effect of each locus that describes how large the phenotypic difference is (e.g., in IgE level) between mice with different alleles at this locus and (b) the explained variance (% of variance) that is the proportion of phenotypic variation in the tested population that is caused by the effects of these alleles. The first parameter in our data varies between 1.4 and 2.5 (i.e., difference between the extreme phenotypes caused by alleles at a locus is between 40% and 150%) and the percent of explained variance 1&#x02013;14. These value ranges are common for majority of quantitative trait loci (QTLs) in the mouse (Flint et al. <xref ref-type="bibr" rid="CR13">2005</xref>).</p><p><bold>Parasite presence in secondary immune organs</bold> is controlled by two loci, <italic>Lmr20</italic> and <italic>Lmr5</italic> (Table <xref rid="Tab3" ref-type="table">3</xref>). <italic>Lmr20</italic> on chromosome 1 is linked to D1Mit403 and it controls parasite load in draining lymph nodes (corrected <italic>P</italic>&#x02009;=&#x02009;5.54&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>). Its BALB/c allele is associated with higher parasite numbers. The effects of <italic>Lmr20</italic> account for 4.25% of variance in parasite load in the lymph nodes. In addition, there was a pronounced sex effect (<italic>P</italic>&#x02009;=&#x02009;10<sup>&#x02212;9</sup>) on parasite numbers in draining lymph nodes and spleen. However, there was no interaction between sex and the marker and no sufficient power to establish whether the effects of <italic>Lmr20</italic> are sex specific. This qualification concerns the effects of the individual <italic>Lmr</italic> loci; the sex difference within the two strains is highly significant (Table <xref rid="Tab1" ref-type="table">1</xref>).<italic>Lmr5</italic> on chromosome 10 is linked to D10Mit12 and it influences parasite load in spleens and splenomegaly (corrected <italic>P</italic>&#x02009;=&#x02009;5.39&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> and 6.98&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>, respectively). The effects of <italic>Lmr5</italic> account for 4.54% of variance in parasite number in spleens and 11.60% of variance in splenomegaly. Higher parasite numbers and a more severe splenomegaly are associated with BALB/c allele. Separate analysis of females and males revealed that <italic>Lmr5</italic> determines parasite numbers in spleen and splenomegaly in females (corrected <italic>P</italic>&#x02009;=&#x02009;5.76&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> and 5.57&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>, respectively). It accounts in females for 11.74% and 14.47% of variance in parasite numbers and splenomegaly, respectively, whereas differences in parasite numbers in spleens and splenomegaly in males were not significant (Table <xref rid="Tab3" ref-type="table">3</xref>). However, absence of interaction between sex and marker and power computations indicated that the present experiments did not have sufficient power to establish whether <italic>Lmr5</italic> has a sex-specific effect. The present data are compatible with additive effects of sex and genotype at <italic>Lmr5</italic>.</p><p><bold>Skin lesions</bold> are controlled by two loci: <italic>Lmr5</italic> and <italic>Lmr21</italic> (Table <xref rid="Tab4" ref-type="table">4</xref> and Fig. <xref rid="Fig2" ref-type="fig">2</xref>). <italic>Lmr5</italic> on chromosome 10 is linked to D10Mit12 and D10Mit46 (corrected <italic>P</italic>&#x02009;=&#x02009;5.27&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup> and 4.83&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>, respectively). <italic>Lmr21</italic> on chromosome 7 is linked to D7Mit67 and D7Mit282 (lesion size on week&#x02009;8; corrected <italic>P</italic>&#x02009;=&#x02009;0.0116 and 0.0972). BALB/c allele of both <italic>Lmr5</italic> and <italic>Lmr21</italic> is associated with larger lesions. The impact of <italic>Lmr5</italic> and <italic>Lmr21</italic> on phenotype is higher in females than in males. In females, <italic>Lmr5</italic> on chromosome 10 is linked with D10Mit12 and D10Mit46 (corrected <italic>P</italic>&#x02009;=&#x02009;2.67&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup> and 7.28&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>, respectively), and <italic>Lmr21</italic> on chromosome 7 is linked with D7Mit67 (corrected <italic>P</italic>&#x02009;=&#x02009;0.046). In males, we did not detect <italic>Lmr5</italic> or <italic>Lmr21.</italic></p><p><bold>Components of the systemic immune response:</bold> Of the four tested components (serum levels of IgE, IFN&#x003b3;, IL-4, and IL-12) we did not detect any linkage of IL-12 levels. The linkages of the other three components involve five loci, <italic>Lmr20, Lmr21, Lmr5, Lmr22</italic> and <italic>Lmr23</italic> (Table <xref rid="Tab5" ref-type="table">5</xref> single gene effects and Tables <xref rid="Tab6" ref-type="table">6</xref>, <xref rid="Tab7" ref-type="table">7</xref>, and <xref rid="Tab8" ref-type="table">8</xref> gene interactions). Serum IgE concentrations are influenced by <italic>Lmr20</italic> and <italic>Lmr5. Lmr20</italic> on chromosome 1 is linked to D1Mit403 (corrected <italic>P</italic>&#x02009;=&#x02009;3.07&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>, 6.09% of variance) and its BALB/c allele is associated with higher serum levels of IgE. Influence of this locus on IgE level is observed only in females (corrected <italic>P</italic>&#x02009;=&#x02009;1.81&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>, 11.76% of variance). <italic>Lmr5</italic> on chromosome 10 is linked to D10Mit12 (corrected <italic>P</italic> value&#x02009;=&#x02009;3.02&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup>, 4.70% of variance). When analyzed separately, females and males exhibit allelic differences of the same size and direction, but do not reach significant <italic>P</italic> values due to insufficient number of mice in the separate sexes. <fig id="Fig2"><label>Fig. 2</label><caption><p>Effects of genotype and sex on size of cutaneous lesion at <italic>Lmr5</italic> (<bold>a</bold>, <bold>b</bold>) and <italic>Lmr21</italic> (<bold>c</bold>, <bold>d</bold>) weeks&#x02009;4 to 8 after infection. The means and standard errors of means (<italic>error bars</italic>) for each of the three genotypes at different time points are given. The numbers of mice for D10Mit12 were 151 females and 144 males; for D7Mit67 149 females and 139 males. <italic>C</italic> and <italic>S</italic> indicate the presence of BALB/c and STS allele, respectively</p></caption><graphic position="anchor" xlink:href="251_2009_392_Fig2_HTML" id="MO2"/></fig>Serum IFN&#x003b3; concentrations are influenced by two inter-locus interactions. <italic>Lmr20</italic> marked by D1Mit403 interacts with <italic>Lmr23</italic> linked to D16Mit73 (Table <xref rid="Tab6" ref-type="table">6</xref>). The highest level of IFN&#x003b3; is observed in STS homozygotes in both loci (corrected <italic>P</italic>&#x02009;=&#x02009;2.01&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup>). This interaction accounts for 6.93% of variance.Serum IFN&#x003b3; level is also controlled by the interaction of <italic>Lmr21</italic> (linked to D7Mit67) with <italic>Lmr5</italic> (linked to D10Mit12) (corrected <italic>P</italic>&#x02009;=&#x02009;1.95&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup>, 7.18% of variance). The lowest IFN&#x003b3; levels are observed either in STS homozygotes at both loci or in BALB/c homozygotes in both loci (Table <xref rid="Tab7" ref-type="table">7</xref>). A separate statistical evaluation of these interactions in females and males was not possible due to the low numbers of mice in some genotypes, but the interaction effects were similar in both sexes (data not shown).Serum IL-4 concentration is influenced by one inter-locus interaction. <italic>Lmr22</italic> marked by D12Mit37 interacts with <italic>Lmr5</italic> linked to D10Mit12. The highest and lowest level of IL-4 is observed in BALB/c and STS homozygotes, respectively, at both loci (corr. <italic>P</italic>&#x02009;=&#x02009;2.69&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup>). This interaction accounts for 7.71% of variance (Table <xref rid="Tab8" ref-type="table">8</xref>).</p><p><bold>Sex differences</bold> in genetic control of lesion size, splenomegaly, and serum level of IgE were revealed when analyzing the male and female F<sub>2</sub> hybrids separately. Influence of sex was high for skin lesions during the whole course of infection (<italic>P</italic>&#x02009;&#x0003c;&#x02009;1.68&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>) and IgE level in serum (<italic>P</italic>&#x02009;=&#x02009;1.41&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup>). The impact of the <italic>Lmr</italic> loci controlling these parameters appears to be stronger in females than in males. However, this influence of sex was independent of the segregating genes, as there was no significant interaction between sex and any of the tested markers.</p></sec><sec id="Sec3" sec-type="discussion"><title>Discussion</title><p>There is extensive literature about genetic control of <italic>L. major</italic>-induced disease (Demant et al. <xref ref-type="bibr" rid="CR11">1996</xref>; Beebe et al. <xref ref-type="bibr" rid="CR4">1997</xref>; Roberts et al. <xref ref-type="bibr" rid="CR39">1997</xref>, <xref ref-type="bibr" rid="CR40">1999</xref>; Lipoldov&#x000e1; et al. <xref ref-type="bibr" rid="CR26">2000</xref>; Badalov&#x000e1; et al. <xref ref-type="bibr" rid="CR1">2002</xref>; Vladimirov et al. <xref ref-type="bibr" rid="CR49">2003</xref>; Havelkov&#x000e1; et al. <xref ref-type="bibr" rid="CR16">2006</xref>), but until now there are no reports on the genetics of parasite elimination. However, the genetics of host&#x02013;pathogen interactions has two important parts: genetics of infection that describes genes that participate in the control of the spread of the infectious agent within the host and genetics of disease development that analyzes the immune and pathological responses of the host. We used genetic dissection to elucidate the functional relationship between the two components of the disease. This study represents the first genome-wide search for loci controlling parasite elimination and dissemination after <italic>L. major</italic> infection. Our results show that these processes correlate only partly.</p><p><bold>Controlling loci and their function</bold> We have detected five loci that in the strain CcS-11 control host&#x02013;parasite interaction (Table <xref rid="Tab2" ref-type="table">2</xref>, Fig. <xref rid="Fig3" ref-type="fig">3</xref>). We have found that parasite numbers in lymph nodes and in spleen are controlled independently: the locus <italic>Lmr20</italic> on chromosome 1 influences parasite load in draining lymph nodes, whereas parasite load in spleen is determined by the locus <italic>Lmr5</italic> on chromosome 10. <italic>Lmr20</italic> is not involved in regulation of skin lesion size, splenomegaly, or hepatomegaly, but it influences systemic immunological changes: it controls serum IgE levels in females, and it interacts with <italic>Lmr23</italic> on chromosome 16 in regulation of IFN&#x003b3; level in serum. <fig id="Fig3"><label>Fig. 3</label><caption><p>Position of the loci that control response to <italic>L. major</italic> in strain CcS-11. The regions of STS and BALB/c origin are represented as <italic>dark</italic> and <italic>white</italic>, respectively; the boundary regions of undetermined origin are <italic>shaded</italic>. Only the markers defining the boundaries the STS-derived segment and the markers that were tested for linkage are shown. The markers that exhibit significant <italic>P</italic> values (corrected for genome-wide search) are shown in <italic>boxes</italic>. The <italic>arrows</italic> indicate the regions of significant linkage</p></caption><graphic position="anchor" xlink:href="251_2009_392_Fig3_HTML" id="MO3"/></fig>The control of spread of parasites to spleen is exercised by another locus&#x02014;<italic>Lmr5</italic>. In females, <italic>Lmr5</italic> controls parasite numbers in spleen and splenomegaly. This locus also influences pathology of another organ (the skin lesions). It has an impact on the systemic immune response by influencing serum IgE level, and in interactions with <italic>Lmr21</italic> on chromosome 7 and <italic>Lmr22</italic> on chromosome 12, also serum levels of IFN&#x003b3; and IL-4, respectively. The BALB/c allele of <italic>Lmr5</italic> is associated with a larger parasite load, splenomegaly, and skin lesion size as well as higher IgE levels.The second locus that controls development of the skin lesions, <italic>Lmr21</italic> on chromosome 7, is not involved in control of parasite load in the lymph nodes nor in the spleen. Loci <italic>Lmr22</italic> (chromosome 12) and <italic>Lmr23</italic> (chromosome 16) control only systemic immune responses&#x02014;serum IL-4 and IFN&#x003b3; level, respectively. They do not affect parasite load, splenomegaly, or skin lesions.It is important to understand that, as in any QTL study, failure to find a linkage between a phenotype and a marker does not rule out that such linkage may exist, although its phenotypic effect are likely smaller than in the detected linkages. So for a QTL, which affects several but not all parameters of a complex disease, this indicates that it has predominant effects on some parameters, although it might modify to a lesser extent other parameters as well.Most loci we describe here affect several phenotypic traits. It is possible that some of these loci contain several linked genes, each affecting a different trait or a different subset of these traits. This is an important issue that needs to be resolved by recombinational analysis, as postulation of separate but linked loci merely on basis of a segregation study could be erroneous because of likely confounding random variations.</p><p><bold>Control of parasite elimination differs between organs</bold> The loci <italic>Lmr20</italic> and <italic>Lmr5</italic> control differentially parasite numbers in lymph nodes and spleen, respectively, suggesting a predominantly organ-specific control of parasite load. This hypothesis is compatible with the mechanistic studies of others. The enzymes inducible nitric oxide synthase and phagocyte NADPH oxidase, which are required for the control of <italic>L. major</italic>, display organ- and stage-specific anti-<italic>Leishmania</italic> effects (Stenger et al. <xref ref-type="bibr" rid="CR46">1996</xref>; Blos et al. <xref ref-type="bibr" rid="CR6">2003</xref>). Inducible nitric oxide synthase has been shown to control resistance to parasites in skin and draining lymph nodes, but not in spleen of resistant strain C57BL/6 (Stenger et al. <xref ref-type="bibr" rid="CR46">1996</xref>). On the other hand, activity of phagocyte NADPH oxidase is essential for the clearance of <italic>L. major</italic> in the spleen, but it is dispensable for the resolution of the acute skin lesions and it exerted only a limited effect on the containment of the parasites in the draining lymph node (Blos et al. <xref ref-type="bibr" rid="CR6">2003</xref>). Similarly, the genes <italic>Lmr20</italic> and <italic>Lmr5</italic> might operate in different pathways of parasite killing or their function might be exerted by mediators produced by cells that influence these pathways.</p><p><bold>Control of cytokine levels and its relationship to organ pathology and parasite numbers</bold> Several <italic>Lmr</italic> loci control IFN&#x003b3; levels in combination with organ or skin pathology and parasite numbers. Different loci control different groups of phenotypes: <italic>Lmr5</italic>&#x02014;organ pathology, parasite numbers in spleen, IFN&#x003b3; level, and IL-4 levels; <italic>Lmr20</italic>&#x02014;parasite numbers in lymph nodes and IFN&#x003b3; level; <italic>Lmr21</italic>&#x02014;organ pathology and IFN&#x003b3; level; <italic>Lmr23</italic>&#x02014;IFN&#x003b3; only (For interaction of these loci see Table <xref rid="Tab2" ref-type="table">2</xref>). This suggests that pathology-controlling and/or parasite-controlling genes <italic>Lmr5</italic>, <italic>Lmr21</italic>, and <italic>Lmr20</italic> might operate via pathways that involve IFN&#x003b3;. Some genes, such as <italic>Lmr22</italic> and <italic>Lmr23</italic>, are involved only in control of systemic immune response. These observations are in agreement with our previous detailed data on relationship of levels of IFN&#x003b3;, IL-12, TNF&#x003b1;, IL-4 and IL-6, and organ pathology (Havelkov&#x000e1; et al. <xref ref-type="bibr" rid="CR16">2006</xref>) that indicated that there is no simple correlation between production of cytokines and development of disease. The influence of individual <italic>Lmr</italic> loci on several phenotypes can be due either to multiple effects of a single gene or these loci may comprise two or more closely linked genes with different effects.</p><p><bold>Sex influence on parasite elimination, organ pathology, and systemic disease</bold> Our data show a sex influence on parasite numbers in secondary immune organs. Although strains BALB/c and CcS-11 did not exhibit any sex influence on lesion size, males of strain CcS-11 contained more parasites in spleens than females and males of both strains had much higher parasite load in lymph nodes. Previously, Mock and Nacy (<xref ref-type="bibr" rid="CR33">1988</xref>) also reported higher parasite numbers in livers of males of BALB/cAnPt, DBA/2N, CDF1 and DBA/2J mice intravenously injected by <italic>L. major</italic>. These data collectively suggest that some genes controlling susceptibility to <italic>L. major</italic> might operate differently in the two sexes; however, we did not find instances of significant marker&#x02013;sex interactions. <italic>Lmr20</italic> influences IgE level in serum only in females. Genes controlling infections that appear to be sex dependent have been observed also with other pathogens. For example, <italic>Rmp4</italic> (resistance to mouse pox 4) controls susceptibility to ectromelia virus in female mice only (Brownstein and Gras <xref ref-type="bibr" rid="CR7">1995</xref>) and <italic>Hrl</italic> (herpes resistance locus) exhibits higher influence on susceptibility to Herpes simplex virus in male than in female mice (Lundberg et al. <xref ref-type="bibr" rid="CR28">2003</xref>). Sex-specific QTLs influence also susceptibility to Theiler&#x02019;s murine encephalomyelitis virus-induced demyelination: loci <italic>Tmved7</italic> and <italic>8</italic> affect male mice only, whereas locus <italic>Tmved9</italic> controls susceptibility only in females. Locus <italic>Tmved6</italic> operates both in females and males, but it has an opposite effect on disease susceptibility in males and females (Butterfield et al. <xref ref-type="bibr" rid="CR8">2003</xref>).</p><p><bold>Potential candidate genes</bold> The <italic>Lmr</italic> loci described here are mapped with a precision of 6&#x02013;30 cM. The regions of the most probable linkage (estimated as the distance of markers that exhibit no significant linkage but are the closest to the markers with linkage) were between 4 and 19 cM long (Fig. <xref rid="Fig3" ref-type="fig">3</xref>), which is customary for the newly detected loci (Flint et al. <xref ref-type="bibr" rid="CR13">2005</xref>). These broad loci contain each several genes that have been shown previously to influence infection with <italic>L. major</italic> or that also influence responses to other pathogens as well as some immunological traits (for references, see Tables <xref rid="Tab9" ref-type="table">9</xref> and <xref rid="Tab10" ref-type="table">10</xref>); however, the effects of many of <italic>Lmr</italic> loci might be caused by genes that are presently not suspected candidates. Presently, we are producing mice with recombinant haplotypes that carry each <italic>Lmr</italic> locus in a very short segment on chromosome. The testing of these strains will restrict the present number of the candidate genes to the most likely ones. <table-wrap id="Tab9"><label>Table 9</label><caption><p>Potential candidate genes for <italic>Lmr</italic> loci controlling response to <italic>L. major</italic> in strain CcS-11</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chr.</th><th>Locus</th><th>Marker</th><th>Position in cM</th><th>Potential candidate gene</th><th>Position in cM</th></tr></thead><tbody><tr><td/><td/><td/><td/><td><italic>Fcer1a</italic>, Fc receptor, IgE, high affinity I, alpha polypeptide (Lewis et al. <xref ref-type="bibr" rid="CR24">2004</xref>)</td><td>94.2</td></tr><tr><td/><td/><td/><td/><td><italic>Fcer1g</italic>, Fc receptor, IgE, high affinity I, gamma polypeptide (Lewis et al. <xref ref-type="bibr" rid="CR24">2004</xref>)</td><td>93.3</td></tr><tr><td/><td/><td/><td/><td><italic>Fcgr2b</italic>, Fc receptor, IgG, low affinity Iib (Padigel and Farrell <xref ref-type="bibr" rid="CR37">2005</xref>; Woelbing et al. <xref ref-type="bibr" rid="CR50">2006</xref>)</td><td>92.3</td></tr><tr><td/><td/><td/><td/><td>Cluster of IFN activated genes (<italic>Ifi201</italic>, <italic>Ifi202a</italic>, <italic>Ifi203</italic>, <italic>Ifi204</italic>, <italic>Ifi505</italic>) (Blos et al. <xref ref-type="bibr" rid="CR6">2003</xref>)</td><td>95.2&#x02013;95.3</td></tr><tr><td>1</td><td><italic>Lmr20</italic></td><td>D1Mit403</td><td>100</td><td><italic>Tgfb2</italic> transforming growth factor, beta 2 (Padigel and Farrell <xref ref-type="bibr" rid="CR37">2005</xref>)</td><td>101.5</td></tr><tr><td colspan="6">&#x000a0;</td></tr><tr><td>7</td><td><italic>Lmr21</italic></td><td>D7Mit67</td><td>63.5</td><td><italic>Il4r</italic>, IL-4 receptor alpha chain (CD124) (Gessner et al. <xref ref-type="bibr" rid="CR14">1994</xref>)</td><td>62.0</td></tr><tr><td colspan="6">&#x000a0;</td></tr><tr><td rowspan="2">10</td><td rowspan="2"><italic>Lmr5</italic></td><td>D10Mit12</td><td>56.0</td><td/><td/></tr><tr><td>D10Mit46</td><td>63.0</td><td><italic>Ifng</italic>, interferon gamma (Nacy et al. <xref ref-type="bibr" rid="CR35">1985</xref>)</td><td>67.0</td></tr><tr><td colspan="6">&#x000a0;</td></tr><tr><td>12</td><td><italic>Lmr22</italic></td><td>D12Mit37</td><td>1.0</td><td><italic>Adam1</italic>7 (a disintegrin and metalloproteinase domain 17) (Moss et al. <xref ref-type="bibr" rid="CR34">1997</xref>)</td><td>3.0</td></tr><tr><td colspan="6">&#x000a0;</td></tr><tr><td rowspan="2">16</td><td rowspan="2"><italic>Lmr23</italic></td><td rowspan="2">D16Mit73</td><td rowspan="2">8.6</td><td rowspan="2">Two clusters of genes that affect B-cell development (<italic>Igl-C5</italic>, <italic>Igll1</italic>, <italic>Vpreb1</italic>, <italic>Vpreb2</italic>; <italic>Igl-C1</italic>, <italic>Igl-C2</italic>, <italic>Igl-C3</italic>, <italic>Igl-V1</italic>, <italic>Igl-V2</italic>, <italic>Igl1-r</italic>) (Hoerauf et al. <xref ref-type="bibr" rid="CR17">1996</xref>; DeKrey et al. <xref ref-type="bibr" rid="CR10">2003</xref>)</td><td>9.8</td></tr><tr><td>13.0</td></tr></tbody></table></table-wrap><table-wrap id="Tab10"><label>Table 10</label><caption><p>Co-mapping with loci controlling other infections and other possibly related QTLs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chr.</th><th>Locus</th><th>Marker</th><th>Position in cM</th><th>Co-localization with other possibly related QTLs</th><th>Position in cM</th></tr></thead><tbody><tr><td rowspan="2" colspan="4"/><td><italic>Tir3c</italic>, trypanosomiasis infection response 3c (Iraqi et al. <xref ref-type="bibr" rid="CR18">2000</xref>)</td><td>93.0</td></tr><tr><td><italic>Ssta2</italic>, susceptibility to <italic>Salmonella typhimurium</italic> antigens 2 (Trezena et al. <xref ref-type="bibr" rid="CR47">2002</xref>)</td><td>95.8</td></tr><tr><td rowspan="5">1</td><td rowspan="5"><italic>Lmr20</italic></td><td rowspan="5">D1Mit403</td><td rowspan="5">100</td><td><italic>Bbaa12</italic>, <italic>Borrelia burgdorferi-</italic>associated arthritis 12 (Roper et al. <xref ref-type="bibr" rid="CR42">2001</xref>)</td><td>96.0</td></tr><tr><td><italic>berr1</italic>, Berghei resistance locus 1 (Bagot et al. <xref ref-type="bibr" rid="CR2">2002</xref>)</td><td>102.0</td></tr><tr><td><italic>Tria4</italic>, T-cell receptor induced activation 4 (Havelkov&#x000e1; et al. <xref ref-type="bibr" rid="CR15">1999</xref>)</td><td>46.0</td></tr><tr><td><italic>Heal6</italic>, wound healing/regeneration 6 (Mcbrearty et al. <xref ref-type="bibr" rid="CR31">1998</xref>)</td><td>52.4</td></tr><tr><td><italic>Tsiq1</italic>, T-cell secretion of IL-4 QTL1 (Choi et al. <xref ref-type="bibr" rid="CR9">2005</xref>)</td><td>59.0</td></tr><tr><td>7</td><td><italic>Lmr21</italic></td><td>D7Mit67</td><td>63.5</td><td><italic>Dice2</italic>, determination of interleukin 4 commitment 2 (Bix et al. <xref ref-type="bibr" rid="CR5">1998</xref>)</td><td>63.5</td></tr><tr><td rowspan="2">12</td><td rowspan="2"><italic>Lmr22</italic></td><td rowspan="2">D12Mit37</td><td rowspan="2">1.0</td><td><italic>Cinda2</italic>, cytokine-induced activation (Krulov&#x000e1; et al. <xref ref-type="bibr" rid="CR21">1997</xref>)</td><td>1.0</td></tr><tr><td><italic>Cd4ts5</italic>, CD4 T-cell subset 5 (Jackson et al. <xref ref-type="bibr" rid="CR19">2003</xref>)</td><td>6.0</td></tr><tr><td>16</td><td><italic>Lmr23</italic></td><td>D16Mit73</td><td>8.6</td><td><italic>Dice1</italic>, determination of interleukin 4 commitment 1 (Bix et al. <xref ref-type="bibr" rid="CR5">1998</xref>; Baguet et al. <xref ref-type="bibr" rid="CR3">2004</xref>)</td><td>8.0</td></tr></tbody></table></table-wrap>In summary, we show that <italic>L. major</italic> parasite load and disease manifestations are controlled by distinct sets of genes. Other genes also determine important immunological and pathological phenotypes of infected mice, but they do not appreciably affect parasite burden. By indicating which of the loci that control immune response and/or organ pathology are involved also in elimination or suppression of the parasite and which are not, these results represent an important step in a progress towards integration of genetic data and results from functional immunological studies.An important corollary of these findings is that in humans there also likely exist polymorphic genes that control numbers of parasites and their organ distribution as well as other genes that affect some components of immune response and/or development or organ pathology but not parasite load. These polymorphisms will result in important individual differences in the &#x0201c;functional architecture&#x0201d; of the disease, its progression being in different individuals driven by different pathways. An apparently identical clinical phenotype in different individuals therefore can result from different functional pathways, and hence could differ in prognosis and response to therapy.</p></sec></body><back><ack><title>Acknowledgement</title><p>Support for this work was provided by the Grant Agency of the Czech Republic (grant 310/06/1745), the European Commission (INTAS Genomics 05-1000004-7761), Academy of Sciences of the Czech Republic (project grant AVOZ50520514), and Ministry of Education of the Czech Republic (project grant LC06009). The work of P. D., L. Q., and A. H. was supported by Roswell Park Cancer Institute&#x02019;s Institutional Funds.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badalov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Svobodov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Vladimirov</surname><given-names>V</given-names></name><name><surname>Vojt&#x000ed;&#x00161;kov&#x000e1;</surname><given-names>J</given-names></name><etal/></person-group><article-title>Separation and mapping of multiple genes that control IgE level in <italic>Leishmania major</italic> infected mice</article-title><source>Genes Immun</source><year>2002</year><volume>3</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6363838</pub-id></citation><citation citation-type="display-unstructured">Badalov&#x000e1; J, Svobodov&#x000e1; M, Havelkov&#x000e1; H, Vladimirov V, Vojt&#x000ed;&#x00161;kov&#x000e1; J et al (2002) Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice. Genes Immun 3:187&#x02013;195 <pub-id pub-id-type="pmid">12058253</pub-id></citation></ref><ref id="CR2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagot</surname><given-names>S</given-names></name><name><surname>Campino</surname><given-names>S</given-names></name><name><surname>Penha-Goncalves</surname><given-names>C</given-names></name><name><surname>Pied</surname><given-names>S</given-names></name><name><surname>Cazenave</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>9919</fpage><lpage>9923</lpage><pub-id pub-id-type="doi">10.1073/pnas.152215199</pub-id></citation><citation citation-type="display-unstructured">Bagot S, Campino S, Penha-Goncalves C, Pied S, Cazenave PA et al (2002) Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc Natl Acad Sci U S A 99:9919&#x02013;9923 <pub-id pub-id-type="pmid">12114535</pub-id></citation></ref><ref id="CR3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baguet</surname><given-names>A</given-names></name><name><surname>Epler</surname><given-names>J</given-names></name><name><surname>Wen Kwun</surname><given-names>W</given-names></name><name><surname>Bix</surname><given-names>M</given-names></name></person-group><article-title>A <italic>Leishmania major</italic> response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1084/jem.20040334</pub-id></citation><citation citation-type="display-unstructured">Baguet A, Epler J, Wen Kwun W, Bix M (2004) A Leishmania major response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus. J Exp Med 200:1605&#x02013;1612 <pub-id pub-id-type="pmid">15596523</pub-id></citation></ref><ref id="CR4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beebe</surname><given-names>AM</given-names></name><name><surname>Mauze</surname><given-names>S</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Coffman</surname><given-names>RL</given-names></name></person-group><article-title>Serial backcross mapping of multiple loci associated with resistance to <italic>Leishmania major</italic> in mice</article-title><source>Immunity</source><year>1997</year><volume>6</volume><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80343-X</pub-id></citation><citation citation-type="display-unstructured">Beebe AM, Mauze S, Schork NJ, Coffman RL (1997) Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551&#x02013;557 <pub-id pub-id-type="pmid">9175833</pub-id></citation></ref><ref id="CR5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bix</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>ZE</given-names></name><name><surname>Thiel</surname><given-names>B</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group><article-title>Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>2289</fpage><lpage>2299</lpage><pub-id pub-id-type="doi">10.1084/jem.188.12.2289</pub-id></citation><citation citation-type="display-unstructured">Bix M, Wang ZE, Thiel B, Schork NJ, Locksley RM (1998) Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cell-intrinsic mechanism. J Exp Med 188:2289&#x02013;2299 <pub-id pub-id-type="pmid">9858515</pub-id></citation></ref><ref id="CR6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blos</surname><given-names>M</given-names></name><name><surname>Schleicher</surname><given-names>U</given-names></name><name><surname>Soares Rocha</surname><given-names>FJ</given-names></name><name><surname>Meissner</surname><given-names>U</given-names></name><name><surname>Rollinghoff</surname><given-names>M</given-names></name><etal/></person-group><article-title>Organ-specific and stage-dependent control of <italic>Leishmania major</italic> infection by inducible nitric oxide synthase and phagocyte NADPH oxidase</article-title><source>Eur J Immunol</source><year>2003</year><volume>33</volume><fpage>1224</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1002/eji.200323825</pub-id></citation><citation citation-type="display-unstructured">Blos M, Schleicher U, Soares Rocha FJ, Meissner U, Rollinghoff M et al (2003) Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol 33:1224&#x02013;1234 <pub-id pub-id-type="pmid">12731047</pub-id></citation></ref><ref id="CR7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brownstein</surname><given-names>DG</given-names></name><name><surname>Gras</surname><given-names>L</given-names></name></person-group><article-title>Chromosome mapping of <italic>Rmp-4</italic>, a gonad-dependent gene encoding host resistance to mousepox</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>6958</fpage><lpage>6964</lpage></citation><citation citation-type="display-unstructured">Brownstein DG, Gras L (1995) Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox. J Virol 69:6958&#x02013;6964 <pub-id pub-id-type="pmid">7474114</pub-id></citation></ref><ref id="CR8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butterfield</surname><given-names>RJ</given-names></name><name><surname>Roper</surname><given-names>RJ</given-names></name><name><surname>Rhein</surname><given-names>DM</given-names></name><name><surname>Melvold</surname><given-names>RW</given-names></name><name><surname>Haynes</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sex-specific quantitative trait loci govern susceptibility to Theiler's murine encephalomyelitis virus-induced demyelination</article-title><source>Genetics</source><year>2003</year><volume>163</volume><fpage>1041</fpage><lpage>1046</lpage></citation><citation citation-type="display-unstructured">Butterfield RJ, Roper RJ, Rhein DM, Melvold RW, Haynes L et al (2003) Sex-specific quantitative trait loci govern susceptibility to Theiler's murine encephalomyelitis virus-induced demyelination. Genetics 163:1041&#x02013;1046 <pub-id pub-id-type="pmid">12663542</pub-id></citation></ref><ref id="CR9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>P</given-names></name><name><surname>Xanthaki</surname><given-names>D</given-names></name><name><surname>Rose</surname><given-names>SJ</given-names></name><name><surname>Haywood</surname><given-names>M</given-names></name><name><surname>Reiser</surname><given-names>H</given-names></name><etal/></person-group><article-title>Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene</article-title><source>Genes Immun</source><year>2005</year><volume>6</volume><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6364192</pub-id></citation><citation citation-type="display-unstructured">Choi P, Xanthaki D, Rose SJ, Haywood M, Reiser H et al (2005) Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene. Genes Immun 6:290&#x02013;297 <pub-id pub-id-type="pmid">15815685</pub-id></citation></ref><ref id="CR10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeKrey</surname><given-names>GK</given-names></name><name><surname>Jones</surname><given-names>JJ</given-names></name><name><surname>Mbow</surname><given-names>ML</given-names></name><name><surname>Brodskyn</surname><given-names>CI</given-names></name><name><surname>Titus</surname><given-names>RG</given-names></name></person-group><article-title>Short report: Requirement of B cells for delayed type hypersensitivity-like pathology after secondary infection with <italic>Leishmania major</italic> in resistant C57BL/6 mice</article-title><source>Am J Trop Med Hyg</source><year>2003</year><volume>69</volume><fpage>481</fpage><lpage>483</lpage></citation><citation citation-type="display-unstructured">DeKrey GK, Jones JJ, Mbow ML, Brodskyn CI, Titus RG (2003) Short report: Requirement of B cells for delayed type hypersensitivity-like pathology after secondary infection with Leishmania major in resistant C57BL/6 mice. Am J Trop Med Hyg 69:481&#x02013;483 <pub-id pub-id-type="pmid">14695084</pub-id></citation></ref><ref id="CR11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demant</surname><given-names>P</given-names></name><name><surname>Lipoldov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Svobodov&#x000e1;</surname><given-names>M</given-names></name></person-group><article-title>Resistance to <italic>Leishmania major</italic> in mice</article-title><source>Science</source><year>1996</year><volume>274</volume><fpage>1392</fpage><lpage>1393</lpage><pub-id pub-id-type="doi">10.1126/science.274.5291.1392</pub-id></citation><citation citation-type="display-unstructured">Demant P, Lipoldov&#x000e1; M, Svobodov&#x000e1; M (1996) Resistance to Leishmania major in mice. Science 274: 1392&#x02013;1393 <pub-id pub-id-type="pmid">8966604</pub-id></citation></ref><ref id="CR12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>LS</given-names></name><name><surname>Herman</surname><given-names>CM</given-names></name></person-group><article-title>Incidence of trypanosomes in the Canada goose as revealed by bone marrow culture</article-title><source>J Parasitol</source><year>1954</year><volume>40</volume><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.2307/3274299</pub-id></citation><citation citation-type="display-unstructured">Diamond LS, Herman CM (1954) Incidence of trypanosomes in the Canada goose as revealed by bone marrow culture. J Parasitol 40:195&#x02013;202 </citation></ref><ref id="CR13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flint</surname><given-names>J</given-names></name><name><surname>Valdar</surname><given-names>W</given-names></name><name><surname>Shifman</surname><given-names>S</given-names></name><name><surname>Mott</surname><given-names>R</given-names></name></person-group><article-title>Strategies for mapping and cloning quantitative trait genes in rodents</article-title><source>Nat Rev Genet</source><year>2005</year><volume>6</volume><fpage>271</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1038/nrg1576</pub-id></citation><citation citation-type="display-unstructured">Flint J, Valdar W, Shifman S, Mott R (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6:271&#x02013;286 <pub-id pub-id-type="pmid">15803197</pub-id></citation></ref><ref id="CR14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gessner</surname><given-names>A</given-names></name><name><surname>Schroppel</surname><given-names>K</given-names></name><name><surname>Will</surname><given-names>A</given-names></name><name><surname>Enssle</surname><given-names>KH</given-names></name><name><surname>Lauffer</surname><given-names>L</given-names></name><etal/></person-group><article-title>Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis</article-title><source>Infect Immun</source><year>1994</year><volume>62</volume><fpage>4112</fpage><lpage>4117</lpage></citation><citation citation-type="display-unstructured">Gessner A, Schroppel K, Will A, Enssle KH, Lauffer L et al (1994) Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis. Infect Immun 62:4112&#x02013;4117 <pub-id pub-id-type="pmid">7927664</pub-id></citation></ref><ref id="CR15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Kosa&#x00159;ov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Krulov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Demant</surname><given-names>P</given-names></name><name><surname>Lipoldov&#x000e1;</surname><given-names>M</given-names></name></person-group><article-title>T-cell proliferative response is controlled by loci <italic>Tria4</italic> and <italic>Tria5</italic> on mouse chromosomes 7 and 9</article-title><source>Mamm Genome</source><year>1999</year><volume>10</volume><fpage>670</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1007/s003359901069</pub-id></citation><citation citation-type="display-unstructured">Havelkov&#x000e1; H, Kosa&#x00159;ov&#x000e1; M, Krulov&#x000e1; M, Demant P, Lipoldov&#x000e1; M (1999) T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse chromosomes 7 and 9. Mamm Genome 10:670&#x02013;674 <pub-id pub-id-type="pmid">10384038</pub-id></citation></ref><ref id="CR16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Badalov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Svobodov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Vojt&#x000ed;&#x00161;kov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Kurey</surname><given-names>I</given-names></name><etal/></person-group><article-title>Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects</article-title><source>Genes Immun</source><year>2006</year><volume>7</volume><fpage>220</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6364290</pub-id></citation><citation citation-type="display-unstructured">Havelkov&#x000e1; H, Badalov&#x000e1; J, Svobodov&#x000e1; M, Vojt&#x000ed;&#x00161;kov&#x000e1; J, Kurey I et al (2006) Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun 7:220&#x02013;233 <pub-id pub-id-type="pmid">16511555</pub-id></citation></ref><ref id="CR17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoerauf</surname><given-names>A</given-names></name><name><surname>Rollinghoff</surname><given-names>M</given-names></name><name><surname>Solbach</surname><given-names>W</given-names></name></person-group><article-title>Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, <italic>Leishmania major</italic>-resistant C.B-17 scid mice by a non-cognate mechanism</article-title><source>Int Immunol</source><year>1996</year><volume>8</volume><fpage>1569</fpage><lpage>1575</lpage><pub-id pub-id-type="doi">10.1093/intimm/8.10.1569</pub-id></citation><citation citation-type="display-unstructured">Hoerauf A, Rollinghoff M, Solbach W (1996) Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism. Int Immunol 8:1569&#x02013;1575 <pub-id pub-id-type="pmid">8921436</pub-id></citation></ref><ref id="CR18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iraqi</surname><given-names>F</given-names></name><name><surname>Clapcott</surname><given-names>SJ</given-names></name><name><surname>Kumari</surname><given-names>P</given-names></name><name><surname>Haley</surname><given-names>CS</given-names></name><name><surname>Kemp</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Fine mapping of trypanosomiasis resistance loci in murine advanced intercross lines</article-title><source>Mamm Genome</source><year>2000</year><volume>11</volume><fpage>645</fpage><lpage>648</lpage><pub-id pub-id-type="doi">10.1007/s003350010133</pub-id></citation><citation citation-type="display-unstructured">Iraqi F, Clapcott SJ, Kumari P, Haley CS, Kemp SJ et al (2000) Fine mapping of trypanosomiasis resistance loci in murine advanced intercross lines. Mamm Genome 11:645&#x02013;648 <pub-id pub-id-type="pmid">10920233</pub-id></citation></ref><ref id="CR19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>AU</given-names></name><name><surname>Galecki</surname><given-names>AT</given-names></name><name><surname>Burke</surname><given-names>DT</given-names></name><name><surname>Miller</surname><given-names>RA</given-names></name></person-group><article-title>Genetic polymorphisms in mouse genes regulating age-sensitive and age-stable T cell subsets</article-title><source>Genes Immun</source><year>2003</year><volume>4</volume><fpage>30</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6363895</pub-id></citation><citation citation-type="display-unstructured">Jackson AU, Galecki AT, Burke DT, Miller RA (2003) Genetic polymorphisms in mouse genes regulating age-sensitive and age-stable T cell subsets. Genes Immun 4:30&#x02013;39 <pub-id pub-id-type="pmid">12595899</pub-id></citation></ref><ref id="CR20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Mack</surname><given-names>D</given-names></name><name><surname>Mui</surname><given-names>E</given-names></name><name><surname>Estes</surname><given-names>R</given-names></name><etal/></person-group><article-title>Genetic analysis of influences on survival following <italic>Toxoplasma gondii</italic> infection</article-title><source>Int J Parasitol</source><year>2002</year><volume>32</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/S0020-7519(01)00321-6</pub-id></citation><citation citation-type="display-unstructured">Johnson J, Suzuki Y, Mack D, Mui E, Estes R et al (2002) Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol 32:179&#x02013;185 <pub-id pub-id-type="pmid">11812495</pub-id></citation></ref><ref id="CR21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krulov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Kosa&#x00159;ov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Hol&#x000e1;&#x00148;</surname><given-names>V</given-names></name><name><surname>Hart</surname><given-names>AAM</given-names></name><etal/></person-group><article-title>IL-2-induced proliferative response is controlled by loci <italic>Cinda1</italic> and <italic>Cinda2</italic> on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations</article-title><source>Genomic</source><year>1997</year><volume>42</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1006/geno.1997.4694</pub-id></citation><citation citation-type="display-unstructured">Krulov&#x000e1; M, Havelkov&#x000e1; H, Kosa&#x00159;ov&#x000e1; M, Hol&#x000e1;&#x00148; V, Hart AAM et al (1997) IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomic 42:11&#x02013;15 </citation></ref><ref id="CR22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>E</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name></person-group><article-title>Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps</article-title><source>Genetics</source><year>1989</year><volume>121</volume><fpage>185</fpage><lpage>199</lpage></citation><citation citation-type="display-unstructured">Lander E, Botstein D (1989) Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121:185&#x02013;199 <pub-id pub-id-type="pmid">2563713</pub-id></citation></ref><ref id="CR23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Schork</surname><given-names>NJ</given-names></name></person-group><article-title>Genetic dissection of complex traits</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>2037</fpage><lpage>2048</lpage><pub-id pub-id-type="doi">10.1126/science.8091226</pub-id></citation><citation citation-type="display-unstructured">Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265:2037&#x02013;2048 <pub-id pub-id-type="pmid">8091226</pub-id></citation></ref><ref id="CR24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>G</given-names></name><name><surname>Rapsomaniki</surname><given-names>E</given-names></name><name><surname>Bouriez</surname><given-names>T</given-names></name><name><surname>Crockford</surname><given-names>T</given-names></name><name><surname>Ferry</surname><given-names>H</given-names></name><etal/></person-group><article-title>Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation</article-title><source>Immunogenetics</source><year>2004</year><volume>56</volume><fpage>564</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1007/s00251-004-0728-4</pub-id></citation><citation citation-type="display-unstructured">Lewis G, Rapsomaniki E, Bouriez T, Crockford T, Ferry H et al (2004) Hyper IgE in New Zealand black mice due to a dominant-negative CD23 mutation. Immunogenetics 56:564&#x02013;571 <pub-id pub-id-type="pmid">15503007</pub-id></citation></ref><ref id="CR25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lipoldov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Demant</surname><given-names>P</given-names></name></person-group><article-title>Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis</article-title><source>Nat Rev Genet</source><year>2006</year><volume>7</volume><fpage>294</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/nrg1832</pub-id></citation><citation citation-type="display-unstructured">Lipoldov&#x000e1; M, Demant P (2006) Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet 7:294&#x02013;305 <pub-id pub-id-type="pmid">16543933</pub-id></citation></ref><ref id="CR26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lipoldov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Svobodov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Krulov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Badalov&#x000e1;</surname><given-names>J</given-names></name><etal/></person-group><article-title>Susceptibility to <italic>Leishmania major</italic> infection in mice: multiple loci and heterogeneity of immunopathological phenotypes</article-title><source>Genes Immun</source><year>2000</year><volume>1</volume><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6363660</pub-id></citation><citation citation-type="display-unstructured">Lipoldov&#x000e1; M, Svobodov&#x000e1; M, Krulov&#x000e1; M, Havelkov&#x000e1; H, Badalov&#x000e1; J et al (2000) Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun 1:200&#x02013;206 <pub-id pub-id-type="pmid">11196712</pub-id></citation></ref><ref id="CR27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lipoldov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Svobodov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Krulov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Badalov&#x000e1;</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis</article-title><source>Immunogenetics</source><year>2002</year><volume>54</volume><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1007/s00251-002-0439-7</pub-id></citation><citation citation-type="display-unstructured">Lipoldov&#x000e1; M, Svobodov&#x000e1; M, Havelkov&#x000e1; H, Krulov&#x000e1; M, Badalov&#x000e1; J et al (2002) Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis. Immunogenetics 54:174&#x02013;183 <pub-id pub-id-type="pmid">12073146</pub-id></citation></ref><ref id="CR28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lundberg</surname><given-names>P</given-names></name><name><surname>Welander</surname><given-names>P</given-names></name><name><surname>Openshaw</surname><given-names>H</given-names></name><name><surname>Nalbandian</surname><given-names>C</given-names></name><name><surname>Edwards</surname><given-names>C</given-names></name><etal/></person-group><article-title>A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>11661</fpage><lpage>11673</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.21.11661-11673.2003</pub-id></citation><citation citation-type="display-unstructured">Lundberg P, Welander P, Openshaw H, Nalbandian C, Edwards C et al (2003) A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J Virol 77:11661&#x02013;11673 <pub-id pub-id-type="pmid">14557652</pub-id></citation></ref><ref id="CR29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Seiler</surname><given-names>KP</given-names></name><name><surname>Eichwald</surname><given-names>EJ</given-names></name><name><surname>Weis</surname><given-names>JH</given-names></name><name><surname>Teuscher</surname><given-names>C</given-names></name><etal/></person-group><article-title>Distinct characteristics of resistance to <italic>Borrelia burgdorferi</italic>-induced arthritis in C57BL/6N mice</article-title><source>Infect Immun</source><year>1998</year><volume>66</volume><fpage>161</fpage><lpage>168</lpage></citation><citation citation-type="display-unstructured">Ma Y, Seiler KP, Eichwald EJ, Weis JH, Teuscher C et al (1998) Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun 66:161&#x02013;168 <pub-id pub-id-type="pmid">9423853</pub-id></citation></ref><ref id="CR30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marinho</surname><given-names>CR</given-names></name><name><surname>Bucci</surname><given-names>DZ</given-names></name><name><surname>Dagli</surname><given-names>ML</given-names></name><name><surname>Bastos</surname><given-names>KR</given-names></name><name><surname>Grisotto</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Pathology affects different organs in two mouse strains chronically infected by a <italic>Trypanosoma cruzi</italic> clone: a model for genetic studies of Chagas' disease</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>2350</fpage><lpage>2357</lpage><pub-id pub-id-type="doi">10.1128/IAI.72.4.2350-2357.2004</pub-id></citation><citation citation-type="display-unstructured">Marinho CR, Bucci DZ, Dagli ML, Bastos KR, Grisotto MG et al (2004) Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect Immun 72:2350&#x02013;2357 <pub-id pub-id-type="pmid">15039360</pub-id></citation></ref><ref id="CR31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McBrearty</surname><given-names>BA</given-names></name><name><surname>Clark</surname><given-names>LD</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Blankenhorn</surname><given-names>EP</given-names></name><name><surname>Heber-Katz</surname><given-names>E</given-names></name></person-group><article-title>Genetic analysis of a mammalian wound-healing trait</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>11792</fpage><lpage>11797</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.20.11792</pub-id></citation><citation citation-type="display-unstructured">McBrearty BA, Clark LD, Zhang XM, Blankenhorn EP, Heber-Katz E (1998) Genetic analysis of a mammalian wound-healing trait. Proc Natl Acad Sci U S A 95:11792&#x02013;11797 <pub-id pub-id-type="pmid">9751744</pub-id></citation></ref><ref id="CR32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMahon-Pratt</surname><given-names>D</given-names></name><name><surname>Alexander</surname><given-names>J</given-names></name></person-group><article-title>Does the <italic>Leishmania major</italic> paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?</article-title><source>Immunol Rev</source><year>2004</year><volume>201</volume><fpage>206</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2004.00190.x</pub-id></citation><citation citation-type="display-unstructured">McMahon-Pratt D, Alexander J (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201:206&#x02013;224 <pub-id pub-id-type="pmid">15361243</pub-id></citation></ref><ref id="CR33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mock</surname><given-names>BA</given-names></name><name><surname>Nacy</surname><given-names>CA</given-names></name></person-group><article-title>Hormonal modulation of sex differences in resistance to <italic>Leishmania major</italic> systemic infections</article-title><source>Infect Immun</source><year>1988</year><volume>56</volume><fpage>3316</fpage><lpage>3319</lpage></citation><citation citation-type="display-unstructured">Mock BA, Nacy CA (1988) Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect Immun 56:3316&#x02013;3319 <pub-id pub-id-type="pmid">3182082</pub-id></citation></ref><ref id="CR34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>ML</given-names></name><name><surname>Jin</surname><given-names>SL</given-names></name><name><surname>Milla</surname><given-names>ME</given-names></name><name><surname>Bickett</surname><given-names>DM</given-names></name><name><surname>Burkhart</surname><given-names>W</given-names></name><etal/></person-group><article-title>Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha</article-title><source>Nature</source><year>1997</year><volume>385</volume><fpage>733</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1038/385733a0</pub-id></citation><citation citation-type="display-unstructured">Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W et al (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733&#x02013;736 <pub-id pub-id-type="pmid">9034191</pub-id></citation></ref><ref id="CR35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nacy</surname><given-names>CA</given-names></name><name><surname>Fortier</surname><given-names>AH</given-names></name><name><surname>Meltzer</surname><given-names>MS</given-names></name><name><surname>Buchmeier</surname><given-names>NA</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name></person-group><article-title>Macrophage activation to kill <italic>Leishmania major</italic>: activation of macrophage for intracellular destruction of amastigotes can be induced by both recombinant interferon- and non-interferon lymphokines</article-title><source>J Immunol</source><year>1985</year><volume>135</volume><fpage>3505</fpage><lpage>3511</lpage></citation><citation citation-type="display-unstructured">Nacy CA, Fortier AH, Meltzer MS, Buchmeier NA, Schreiber RD (1985) Macrophage activation to kill Leishmania major: activation of macrophage for intracellular destruction of amastigotes can be induced by both recombinant interferon- and non-interferon lymphokines. J Immunol 135:3505&#x02013;3511 <pub-id pub-id-type="pmid">3930606</pub-id></citation></ref><ref id="CR36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olivier</surname><given-names>M</given-names></name><name><surname>Gregory</surname><given-names>DJ</given-names></name><name><surname>Forget</surname><given-names>G</given-names></name></person-group><article-title>Subversion mechanisms by which <italic>Leishmania</italic> parasites can escape the host immune response: a signaling point of view</article-title><source>Clin Microbiol Rev</source><year>2005</year><volume>18</volume><fpage>293</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1128/CMR.18.2.293-305.2005</pub-id></citation><citation citation-type="display-unstructured">Olivier M, Gregory DJ, Forget G (2005) Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18:293&#x02013;305 <pub-id pub-id-type="pmid">15831826</pub-id></citation></ref><ref id="CR37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padigel</surname><given-names>UM</given-names></name><name><surname>Farrell</surname><given-names>JP</given-names></name></person-group><article-title>Control of infection with <italic>Leishmania major</italic> in susceptible BALB/c mice lacking the common (gamma)-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><fpage>6340</fpage><lpage>6345</lpage></citation><citation citation-type="display-unstructured">Padigel UM, Farrell JP (2005) Control of infection with Leishmania major in susceptible BALB/c mice lacking the common (gamma)-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J Immunol 174:6340&#x02013;6345 <pub-id pub-id-type="pmid">15879134</pub-id></citation></ref><ref id="CR38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>R&#x000e5;berg</surname><given-names>L</given-names></name><name><surname>Sim</surname><given-names>D</given-names></name><name><surname>Read</surname><given-names>AF</given-names></name></person-group><article-title>Disentangling genetic variation for resistance and tolerance to infectious diseases in animals</article-title><source>Science</source><year>2007</year><volume>318</volume><fpage>812</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1126/science.1148526</pub-id></citation><citation citation-type="display-unstructured">R&#x000e5;berg L, Sim D, Read AF (2007) Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318:812&#x02013;814 <pub-id pub-id-type="pmid">17975068</pub-id></citation></ref><ref id="CR39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>LJ</given-names></name><name><surname>Baldwin</surname><given-names>TM</given-names></name><name><surname>Curtis</surname><given-names>JM</given-names></name><name><surname>Handman</surname><given-names>E</given-names></name><name><surname>Foote</surname><given-names>SJ</given-names></name></person-group><article-title>Resistance to <italic>Leishmania major</italic> is linked to H2 region on chromosome 17 and to chromosome 9</article-title><source>J Exp Med</source><year>1997</year><volume>9</volume><fpage>1705</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1084/jem.185.9.1705</pub-id></citation><citation citation-type="display-unstructured">Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ (1997) Resistance to Leishmania major is linked to H2 region on chromosome 17 and to chromosome 9. J Exp Med 9:1705&#x02013;1710 <pub-id pub-id-type="pmid">9151907</pub-id></citation></ref><ref id="CR40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>LJ</given-names></name><name><surname>Baldwin</surname><given-names>TM</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name><name><surname>Handman</surname><given-names>E</given-names></name><name><surname>Foote</surname><given-names>SJ</given-names></name></person-group><article-title>Chromosomes X, 9, and the H2 locus interact epistatically to control <italic>Leishmania major</italic> infection</article-title><source>Eur J Immunol</source><year>1999</year><volume>29</volume><fpage>3047</fpage><lpage>3050</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199909)29:09&#x0003c;3047::AID-IMMU3047&#x0003e;3.0.CO;2-L</pub-id></citation><citation citation-type="display-unstructured">Roberts LJ, Baldwin TM, Speed TP, Handman E, Foote SJ (1999) Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection. Eur J Immunol 29:3047&#x02013;3050 <pub-id pub-id-type="pmid">10508279</pub-id></citation></ref><ref id="CR41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>MR</given-names></name><name><surname>Popper</surname><given-names>SJ</given-names></name><name><surname>Wirth</surname><given-names>DF</given-names></name></person-group><article-title>Amplification of kinetoplast DNA as a tool in the detection and diagnosis of <italic>Leishmania</italic></article-title><source>Exp Parasitol</source><year>1990</year><volume>71</volume><fpage>267</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/0014-4894(90)90031-7</pub-id></citation><citation citation-type="display-unstructured">Rodgers MR, Popper SJ, Wirth DF (1990) Amplification of kinetoplast DNA as a tool in the detection and diagnosis of Leishmania. Exp Parasitol 71:267&#x02013;275 <pub-id pub-id-type="pmid">2170165</pub-id></citation></ref><ref id="CR42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roper</surname><given-names>RJ</given-names></name><name><surname>Weis</surname><given-names>JJ</given-names></name><name><surname>McCracken</surname><given-names>BA</given-names></name><name><surname>Green</surname><given-names>CB</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses</article-title><source>Genes Immun</source><year>2001</year><volume>2</volume><fpage>388</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1038/sj.gene.6363801</pub-id></citation><citation citation-type="display-unstructured">Roper RJ, Weis JJ, McCracken BA, Green CB, Ma Y et al (2001) Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun 2:388&#x02013;397 <pub-id pub-id-type="pmid">11704805</pub-id></citation></ref><ref id="CR43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>D</given-names></name><name><surname>Noben-Trauth</surname><given-names>N</given-names></name></person-group><article-title>The immunology of susceptibility and resistance to <italic>Leishmania major</italic> in mice</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>845</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1038/nri933</pub-id></citation><citation citation-type="display-unstructured">Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845&#x02013;858 <pub-id pub-id-type="pmid">12415308</pub-id></citation></ref><ref id="CR44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>JB</given-names></name><name><surname>Hill</surname><given-names>AE</given-names></name><name><surname>Nadeau</surname><given-names>JH</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><article-title>Mapping quantitative trait loci for anxiety in chromosome substitution strains of mice</article-title><source>Genetics</source><year>2005</year><volume>169</volume><fpage>855</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1534/genetics.104.031492</pub-id></citation><citation citation-type="display-unstructured">Singer JB, Hill AE, Nadeau JH, Lander ES (2005) Mapping quantitative trait loci for anxiety in chromosome substitution strains of mice. Genetics 169:855&#x02013;862 <pub-id pub-id-type="pmid">15371360</pub-id></citation></ref><ref id="CR45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stassen</surname><given-names>APM</given-names></name><name><surname>Groot</surname><given-names>PC</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Demant</surname><given-names>P</given-names></name></person-group><article-title>Genetic composition of the recombinant congenic strains</article-title><source>Mamm Genome</source><year>1996</year><volume>7</volume><fpage>55</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s003359900013</pub-id></citation><citation citation-type="display-unstructured">Stassen APM, Groot PC, Eppig JT, Demant P (1996) Genetic composition of the recombinant congenic strains. Mamm Genome 7:55&#x02013;58 <pub-id pub-id-type="pmid">8903730</pub-id></citation></ref><ref id="CR46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Donhauser</surname><given-names>N</given-names></name><name><surname>Thuring</surname><given-names>H</given-names></name><name><surname>Rollinghoff</surname><given-names>M</given-names></name><name><surname>Bogdan</surname><given-names>C</given-names></name></person-group><article-title>Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>1501</fpage><lpage>1514</lpage><pub-id pub-id-type="doi">10.1084/jem.183.4.1501</pub-id></citation><citation citation-type="display-unstructured">Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C (1996) Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183:1501&#x02013;1514 <pub-id pub-id-type="pmid">8666908</pub-id></citation></ref><ref id="CR47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trezena</surname><given-names>AG</given-names></name><name><surname>Souza</surname><given-names>CM</given-names></name><name><surname>Borrego</surname><given-names>A</given-names></name><name><surname>Massa</surname><given-names>S</given-names></name><name><surname>Siqueira</surname><given-names>M</given-names></name><etal/></person-group><article-title>Co-localization of quantitative trait loci regulating resistance to <italic>Salmonella typhimurium</italic> infection and specific antibody production phenotypes</article-title><source>Microbes Infect</source><year>2002</year><volume>4</volume><fpage>1409</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1016/S1286-4579(02)00023-0</pub-id></citation><citation citation-type="display-unstructured">Trezena AG, Souza CM, Borrego A, Massa S, Siqueira M et al (2002) Co-localization of quantitative trait loci regulating resistance to Salmonella typhimurium infection and specific antibody production phenotypes. Microbes Infect 4:1409&#x02013;1415 <pub-id pub-id-type="pmid">12475631</pub-id></citation></ref><ref id="CR48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tripodis</surname><given-names>N</given-names></name><name><surname>Hart</surname><given-names>AA</given-names></name><name><surname>Fijneman</surname><given-names>RJ</given-names></name><name><surname>Demant</surname><given-names>P</given-names></name></person-group><article-title>Complexity of lung tumor modifiers: mapping of thirty genes and twenty five interactions in half of the mouse genome</article-title><source>J Natl Cancer Inst</source><year>2001</year><volume>93</volume><fpage>1484</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.1093/jnci/93.19.1484</pub-id></citation><citation citation-type="display-unstructured">Tripodis N, Hart AA, Fijneman RJ, Demant P (2001) Complexity of lung tumor modifiers: mapping of thirty genes and twenty five interactions in half of the mouse genome. J Natl Cancer Inst 93:1484&#x02013;1489 <pub-id pub-id-type="pmid">11584065</pub-id></citation></ref><ref id="CR49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vladimirov</surname><given-names>V</given-names></name><name><surname>Badalov&#x000e1;</surname><given-names>J</given-names></name><name><surname>Svobodov&#x000e1;</surname><given-names>M</given-names></name><name><surname>Havelkov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Hart</surname><given-names>AAM</given-names></name><etal/></person-group><article-title>Different genetic control of cutaneous and visceral disease after <italic>Leishmania major</italic> infection in mouse</article-title><source>Infect Immun</source><year>2003</year><volume>71</volume><fpage>2041</fpage><lpage>2046</lpage><pub-id pub-id-type="doi">10.1128/IAI.71.4.2041-2046.2003</pub-id></citation><citation citation-type="display-unstructured">Vladimirov V, Badalov&#x000e1; J, Svobodov&#x000e1; M, Havelkov&#x000e1; H, Hart AAM et al (2003) Different genetic control of cutaneous and visceral disease after Leishmania major infection in mouse. Infect Immun 71:2041&#x02013;2046 <pub-id pub-id-type="pmid">12654824</pub-id></citation></ref><ref id="CR50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woelbing</surname><given-names>F</given-names></name><name><surname>Kostka</surname><given-names>SL</given-names></name><name><surname>Moelle</surname><given-names>K</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Sunderkoetter</surname><given-names>C</given-names></name><etal/></person-group><article-title>Uptake of <italic>Leishmania major</italic> by dendritic cells is mediated by Fc(gamma) receptors and facilitates acquisition of protective immunity</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1084/jem.20052288</pub-id></citation><citation citation-type="display-unstructured">Woelbing F, Kostka SL, Moelle K, Belkaid Y, Sunderkoetter C et al (2006) Uptake of Leishmania major by dendritic cells is mediated by Fc(gamma) receptors and facilitates acquisition of protective immunity. J Exp Med 203:177&#x02013;188 <pub-id pub-id-type="pmid">16418399</pub-id></citation></ref></ref-list></back></article> 